<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Epigenetics</journal-id><journal-id journal-id-type="iso-abbrev">Epigenetics</journal-id><journal-id journal-id-type="publisher-id">KEPI</journal-id><journal-id journal-id-type="publisher-id">kepi20</journal-id><journal-title-group><journal-title>Epigenetics</journal-title></journal-title-group><issn pub-type="ppub">1559-2294</issn><issn pub-type="epub">1559-2308</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5048723</article-id><article-id pub-id-type="publisher-id">1208891</article-id><article-id pub-id-type="doi">10.1080/15592294.2016.1208891</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk</article-title><alt-title alt-title-type="running-authors">A. CHEONG ET&#x000a0;AL.</alt-title><alt-title alt-title-type="running-title">Epigenetics</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cheong</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref><xref ref-type="author-notes" rid="afn0001"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xiang</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref><xref ref-type="author-notes" rid="afn0001"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cheung</surname><given-names>Yuk-Yin</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="author-notes" rid="afn0002"><sup>**</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Wan-yee</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref><xref ref-type="author-notes" rid="afn0003"><sup>#</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="author-notes" rid="afn0004"><sup>##</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Shu-Hua</given-names></name><xref ref-type="aff" rid="af0003"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Medvedovic</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref><xref ref-type="aff" rid="af0004"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Leung</surname><given-names>Yuet-Kin</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref><xref ref-type="aff" rid="af0004"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Prins</surname><given-names>Gail S.</given-names></name><xref ref-type="aff" rid="af0003"><sup>c</sup></xref><xref ref-type="aff" rid="af0005"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ho</surname><given-names>Shuk-Mei</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref><xref ref-type="aff" rid="af0004"><sup>d</sup></xref><xref ref-type="aff" rid="af0006"><sup>f</sup></xref><xref ref-type="corresp" rid="an0001"/></contrib><aff id="af0001"><label>a</label><institution>Department of Environmental Health, University of Cincinnati College of Medicine</institution>, Cincinnati, OH, <country>USA</country></aff><aff id="af0002"><label>b</label><institution>Center for Environmental Genetics, University of Cincinnati College of Medicine</institution>, Cincinnati, OH, <country>USA</country></aff><aff id="af0003"><label>c</label><institution>Department of Urology, College of Medicine, University of Illinois at Chicago</institution>, Chicago, IL, <country>USA</country></aff><aff id="af0004"><label>d</label><institution>Cincinnati Cancer Center</institution>, Cincinnati, OH, <country>USA</country></aff><aff id="af0005"><label>e</label><institution>University of Illinois Cancer Center</institution>, Chicago, IL, <country>USA</country></aff><aff id="af0006"><label>f</label><institution>Cincinnati Veteran Affairs Hospital Medical Center</institution>, Cincinnati, OH, <country>USA</country></aff></contrib-group><author-notes><fn id="afn0005"><p>Supplemental data for this article can be accessed on the <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/15592294.2016.1208891">publisher's website</ext-link>.</p></fn><fn id="afn0001"><label>*</label><p>These authors contributed equally to this work.</p></fn><fn id="afn0002"><label>**</label><p>Current address: Life Giving Foundation Education Center, Cheung Sha Wan, Kowloon, Hong Kong</p></fn><fn id="afn0003"><label>#</label><p>Current address: Department of Environmental Health Sciences, John Hopkins Bloomberg School of Public Health, Baltimore, MD, USA</p></fn><fn id="afn0004"><label>##</label><p>Current address: Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA</p></fn><corresp id="an0001"><bold>CONTACT</bold> Shuk-Mei Ho <email xlink:href="hosm@ucmail.uc.edu">hosm@ucmail.uc.edu</email><institution>Room 128, Department of Environmental Health, Kettering, Complex, 160 Panzeca Way University of Cincinnati Medical Center</institution> Cincinnati, OH 45267-0056, <country>USA</country>.</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>14</day><month>7</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>7</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>11</volume><issue>9</issue><fpage seq="5">674</fpage><lpage>689</lpage><history><date date-type="received"><day>25</day><month>4</month><year>2016</year></date><date date-type="rev-recd"><day>25</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>27</day><month>6</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="description"> &#x000a9; Ana Cheong, Xiang Zhang, Yuk-Yin Cheung, Wan-yee Tang, Jing Chen, Shu-Hua Ye, Mario Medvedovic, Yuet-Kin Leung, Gail S. Prins, and Shuk-Mei Ho. <copyright-statement>--><copyright-statement>&#x000a9; 2016 The Author(s). Published with license by Taylor &#x00026; Francis Group, LLC</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="kepi-11-09-1208891.pdf"/><abstract><title>ABSTRACT</title><p>Developmental exposure to endocrine-disrupting chemicals (EDCs), 17&#x003b2;-estradiol-3-benzoate (EB) and bisphenol A (BPA), increases susceptibility to prostate cancer (PCa) in rodent models. Here, we used the methylated-CpG island recovery assay (MIRA)-assisted genomic tiling and CpG island arrays to identify treatment-associated methylome changes in the postnatal day (PND)90 dorsal prostate tissues of Sprague-Dawley rats neonatally (PND1, 3, and 5) treated with 25&#x000a0;&#x000b5;g/pup or 2,500&#x000a0;&#x000b5;g EB/kg body weight (BW) or 0.1&#x000a0;&#x000b5;g BPA/pup or 10&#x000a0;&#x000b5;g BPA/kg BW. We identified 111 EB-associated and 86 BPA-associated genes, with 20 in common, that have significant differentially methylated regions. Pathway analysis revealed cancer as the top common disease pathway. Bisulfite sequencing validated the differential methylation patterns observed by array analysis in 15 identified candidate genes. The methylation status of 7 (<italic>Pitx3, Wnt10b, Paqr4, Sox2, Chst14, Tpd52, Creb3l4</italic>) of these 15 genes exhibited an inverse correlation with gene expression in tissue samples. Cell-based assays, using 5-aza-cytidine-treated normal (NbE-1) and cancerous (AIT) rat prostate cells, added evidence of DNA methylation-mediated gene expression of 6 genes (exception: <italic>Paqr4</italic>). Functional connectivity of these genes was linked to embryonic stem cell pluripotency. Furthermore, clustering analyses using the dataset from The Cancer Genome Atlas revealed that expression of this set of 7 genes was associated with recurrence-free survival of PCa patients. In conclusion, our study reveals that gene-specific promoter methylation changes, resulting from early-life EDC exposure in the rat, may serve as predictive epigenetic biomarkers of PCa recurrence, and raises the possibility that such exposure may impact human disease.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Developmental origin of health and disease (DOHaD)</kwd><kwd>early-life reprogramming</kwd><kwd>endocrine-disrupting chemicals (EDCs)</kwd><kwd>epigenetics</kwd><kwd>Ingenuity&#x000ae; </kwd><kwd>Pathway Analysis (IPA&#x000ae;)</kwd><kwd>methylated-CpG island recovery assay (MIRA)</kwd><kwd>NimbleGen rat DNA methylation promoter array</kwd><kwd>Sprague Dawley rats</kwd><kwd>stem cell pluripotency</kwd><kwd>The Cancer Genome Atlas (TCGA)</kwd></kwd-group><counts><fig-count count="6"/><table-count count="3"/><ref-count count="100"/><page-count count="16"/></counts></article-meta></front><body><sec><title>Abbreviations</title><p>
<def-list><def-item><term>AA</term><def><p>African-American</p></def></def-item><def-item><term>Acrbp</term><def><p>Acrosin binding protein 21</p></def></def-item><def-item><term>AIT</term><def><p>Rat prostate cancer cell line</p></def></def-item><def-item><term>Akt</term><def><p>Protein kinase B</p></def></def-item><def-item><term>5-aza</term><def><p>5-aza-cytidine</p></def></def-item><def-item><term>BPA</term><def><p>Bisphenol A</p></def></def-item><def-item><term>Btbd3</term><def><p>BTB domain containing 3</p></def></def-item><def-item><term>BW</term><def><p>Body weight</p></def></def-item><def-item><term>Ccdc67</term><def><p>Coiled-coil domain containing protein 67</p></def></def-item><def-item><term>Chad</term><def><p>Chondoadherin</p></def></def-item><def-item><term>Chst14</term><def><p>Carbohydrate sulfotransferase 14</p></def></def-item><def-item><term>Creb3l4</term><def><p>Cyclic AMP responsive element binding protein 3-like 4</p></def></def-item><def-item><term>Ctrl</term><def><p>Control</p></def></def-item><def-item><term>DMR</term><def><p>Differentially methylated region</p></def></def-item><def-item><term>Dnase2b</term><def><p>Deoxyribonuclease II &#x003b2;</p></def></def-item><def-item><term>Dnmt3a</term><def><p>DNA methyltransferase 3a</p></def></def-item><def-item><term>Dnmt3b</term><def><p>DNA methyltransferase 3b</p></def></def-item><def-item><term>E<sub>2</sub></term><def><p>17&#x003b2;-estradiol</p></def></def-item><def-item><term>EB</term><def><p>17&#x003b2;-estradiol-3-benzoate</p></def></def-item><def-item><term>EDC</term><def><p>Endocrine-disrupting chemical</p></def></def-item><def-item><term>ER</term><def><p>Estrogen receptor</p></def></def-item><def-item><term>ERK1/2</term><def><p>Extracellular-signal-regulated kinase 1/2</p></def></def-item><def-item><term>ERR&#x003b3;</term><def><p>Estrogen related receptor gamma</p></def></def-item><def-item><term>ESR1/ER&#x003b1;</term><def><p>Estrogen receptor &#x003b1;</p></def></def-item><def-item><term>ESR2/ER&#x003b2;</term><def><p>Estrogen receptor &#x003b2;</p></def></def-item><def-item><term>GPER1/GPR30</term><def><p>G protein-coupled estrogen receptor 1</p></def></def-item><def-item><term>Hmgn5</term><def><p>High mobility group nucleosome binding domain 5</p></def></def-item><def-item><term>Habp2</term><def><p>Hyaluronan binding protein 2</p></def></def-item><def-item><term>Hpcal1</term><def><p>Hippocalcin-like 1</p></def></def-item><def-item><term>IPA</term><def><p>Ingenuity Pathway Analysis</p></def></def-item><def-item><term>Krt83</term><def><p>Keratin 83</p></def></def-item><def-item><term>Mbd2</term><def><p>Methyl-CpG binding domain protein 2</p></def></def-item><def-item><term>Mbd4</term><def><p>Methyl-CpG binding domain protein 4</p></def></def-item><def-item><term>MIRA</term><def><p>Methylated-CpG island recovery assay</p></def></def-item><def-item><term>NbE-1</term><def><p>Rat prostate epithelial cell line</p></def></def-item><def-item><term>Nfia</term><def><p>Nuclear factor I/A</p></def></def-item><def-item><term>Osbpl6</term><def><p>Oxysterol binding protein-like 6</p></def></def-item><def-item><term>Paqr4</term><def><p>Progestin and adipoQ receptor family member 4</p></def></def-item><def-item><term>PCa</term><def><p>Prostate cancer</p></def></def-item><def-item><term>Pde4d</term><def><p>Phosphodiesterase type IV variant</p></def></def-item><def-item><term>Phpt1</term><def><p>Phosphohistidine phosphatase 1</p></def></def-item><def-item><term>Pitx3</term><def><p>Paired-like homeodomain 3</p></def></def-item><def-item><term>PIN</term><def><p>Prostatic intraepithelial neoplasia</p></def></def-item><def-item><term>PND</term><def><p>Postnatal day</p></def></def-item><def-item><term>Prkar1a</term><def><p>Protein kinase cAMP-dependent type 1 regulatory subunit &#x003b1;</p></def></def-item><def-item><term>Rbpjl</term><def><p>Recombination signal binding protein for immunoglobulin kappa J region-like</p></def></def-item><def-item><term>Rnf186</term><def><p>Ring finger protein 186</p></def></def-item><def-item><term>Rpl19</term><def><p>Ribosomal protein L19</p></def></def-item><def-item><term>SD</term><def><p>Sprague Dawley</p></def></def-item><def-item><term>SEM</term><def><p>Standard error of mean</p></def></def-item><def-item><term>Sox2</term><def><p>Sex determining region Y box 2</p></def></def-item><def-item><term>Tacstd2</term><def><p>Tumor-associated calcium signal transducer 2</p></def></def-item><def-item><term>Tbx4</term><def><p>T-box 4</p></def></def-item><def-item><term>TCGA</term><def><p>The Cancer Genome Atlas</p></def></def-item><def-item><term>TGF&#x003b2;</term><def><p>Transforming growth factor &#x003b2;</p></def></def-item><def-item><term>Tmem27</term><def><p>Transmembrane protein 27</p></def></def-item><def-item><term>TNBC</term><def><p>Triple negative breast cancer</p></def></def-item><def-item><term>Tpd52</term><def><p>Tumor protein D52</p></def></def-item><def-item><term>Tymp</term><def><p>Thymidine phosphorylase</p></def></def-item><def-item><term>Wnt10b</term><def><p>Wingless-type MMTV integration site family, member 10B</p></def></def-item></def-list></p></sec><sec sec-type="intro" id="s0001"><title>Introduction</title><p>Exposure to environmental agents is a risk factor for multiple diseases. Evidence is mounting in support of the causal link between exposure to xenoestrogens and human diseases,<xref rid="cit0001" ref-type="bibr"><sup>1-3</sup></xref> including cancer.<xref rid="cit0004" ref-type="bibr"><sup>4-7</sup></xref> Bisphenol A (BPA) is a ubiquitous environmental xenoestrogen widely used during the production of polycarbonate plastics, epoxy resins, carbonless receipt paper, and hundreds of other manufactured products.<xref rid="cit0001" ref-type="bibr"><sup>1</sup></xref> The fact that urinary BPA is detectable in &#x0003e;95% of the US population<xref rid="cit0008" ref-type="bibr"><sup>8</sup></xref> indicates that BPA readily leaches into the environment, contaminates our food and water, and enters our bodies. Chronic exposure to BPA in rodents<xref rid="cit0009" ref-type="bibr"><sup>9</sup></xref> and in humans<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> is associated with prostate cancer (PCa) and its pre-lesions. Moreover, BPA is detectable in umbilical cord blood<xref rid="cit0011" ref-type="bibr"><sup>11-14</sup></xref> and sera of newborns,<xref rid="cit0015" ref-type="bibr"><sup>15</sup></xref> which elevates the concern of early-life BPA exposure and development of later-life disease. As an endocrine disrupting chemical (EDC), BPA binds to estrogen receptors (ERs) ESR1, ESR2, and GPER1,<xref rid="cit0016" ref-type="bibr"><sup>16</sup></xref> which are expressed in the rodent and human prostate epithelial cells.<xref rid="cit0017" ref-type="bibr"><sup>17,18</sup></xref> While affinity for nuclear ERs is low compared to estradiol-17&#x003b2;, BPA has equivalent activational capacities for membrane ERs<xref rid="cit0016" ref-type="bibr"><sup>16,19</sup></xref> and rapid actions of low-dose BPA have been documented in prostate cells.<xref rid="cit0019" ref-type="bibr"><sup>19</sup></xref> Finally, BPA can also signal through non-ER pathways.<xref rid="cit0020" ref-type="bibr"><sup>20,21</sup></xref></p><p>Like BPA, 17&#x003b2;-estradiol-3-benzoate (EB) is a ubiquitous environmental agent. It is an estradiol analog commonly used in livestock for inducing weight gain and synchronizing estrus cycles in heifers and cattle.<xref rid="cit0022" ref-type="bibr"><sup>22</sup></xref> Since EB binds ERs with high affinity,<xref rid="cit0023" ref-type="bibr"><sup>23</sup></xref> unintended exposures may trigger estrogenic responses that compromise health. In rodents, neonatal EB exposure (30&#x02013;125&#x000a0;ng/day in mouse and 125&#x02013;500&#x000a0;ng/day in rats) has been shown to induce the production of morphologically abnormal sperm during adulthood.<xref rid="cit0024" ref-type="bibr"><sup>24</sup></xref> Similarly, rats neonatally exposed to 25&#x000a0;&#x000b5;g EB developed prostates with a greater risk of malignant changes with aging, including severe prostatic intraepithelial neoplasia (PIN), a precancerous condition.<xref rid="cit0025" ref-type="bibr"><sup>25-27</sup></xref> Since production of morphologically abnormal sperm<xref rid="cit0024" ref-type="bibr"><sup>24</sup></xref> and induction of increased susceptibility to hormonal carcinogenesis<xref rid="cit0025" ref-type="bibr"><sup>25</sup></xref> are similarly observed following neonatal BPA exposure, these findings strongly implicate early-life as a susceptible window for environmental xenoestrogens to predispose later-life disease risk and EB can serve as a positive estrogen control in studies of weaker estrogenic agents such as BPA. While emerging evidence indicates that epigenetic modifications are involved,<xref rid="cit0025" ref-type="bibr"><sup>25,28-33</sup></xref> the molecular underpinnings of this process remain to be fully clarified.</p><p>To initially interrogate whether neonatal exposure to EB and BPA reprogrammed the prostate epigenome, we exposed rats to an environmentally relevant dose of BPA [10 &#x003bc;g/kg body weight (BW)] or EB (2,500&#x000a0;&#x003bc;g/kg BW) on postnatal days 1, 3, and 5. We observed that this transient developmental exposure increased the dorsal and lateral prostate lobe susceptibility to adult-onset E<sub>2</sub>-induced carcinogenesis, markedly augmenting the incidence and severity of lesions as compared to oil-treated controls.<xref rid="cit0025" ref-type="bibr"><sup>25,32,34</sup></xref> Using methylation-sensitive restriction fingerprinting to identify altered DNA methylation marks, we found that neonatal EB and BPA exposures were associated with the dysregulation of <italic>phosphodiesterase type IV variant 4 (Pde4d4</italic>),<xref rid="cit0025" ref-type="bibr"><sup>25</sup></xref>
<italic>hippocalcin-like 1 (Hpcal1</italic>; also known as <italic>visinin-like protein</italic>-3, <italic>Vilip-3</italic>), and <italic>high mobility group nucleosome binding domain 5 (Hmgn5</italic>; formerly known as <italic>nucleosome binding protein 1, Nsbp1</italic>)<xref rid="cit0032" ref-type="bibr"><sup>32</sup></xref> through aberrant promoter methylation detected on postnatal day (PND)10, 90, and 200. Together, these findings provided the first evidence that early&#x02013;life environmental exposure to EDC reprogrammed the prostate epigenome and identified a developmental basis of PCa risk with aging. Moreover, the expression of <italic>DNA methylation transferase3a</italic> and <italic>3b (Dnmt3a</italic> and <italic>Dnmt3b</italic>) and <italic>methyl-CpG binding domain protein2</italic> and <italic>4 (Mbd2</italic> and <italic>Mbd4</italic>) was upregulated in PND10 and 90 prostate tissues,<xref rid="cit0032" ref-type="bibr"><sup>32</sup></xref> providing a mechanistic basis for reprogramming of DNA methylation marks upon early-life EDC exposure. Thus, we propose that differential methylation of genes that persist in the PND90 prostate primes the tissue for heightened sensitivity to a secondary exposure to rising estradiol later in life, as occurs in aging males.<xref rid="cit0035" ref-type="bibr"><sup>35</sup></xref> This is particularly relevant since elevated estrogens have been associated with increased PCa risk in men<xref rid="cit0006" ref-type="bibr"><sup>6</sup></xref> and are sufficient to transform the human prostate epithelium.<xref rid="cit0017" ref-type="bibr"><sup>17</sup></xref></p><p>While these findings had a major impact on the field of EDC research and developmental basis of carcinogenesis,<xref rid="cit0036" ref-type="bibr"><sup>36</sup></xref> a genome-wide search for additional DNA methylation targets of neonatal exposure to xenoestrogens is warranted for an unbiased discovery of other epigenetic marks that may underlie increased PCa risk with aging. To accomplish this goal, we herein used the methylated-CpG island recovery assay (MIRA)-assisted genomic tiling and CpG island array analysis and identified distinct and common EB-/BPA-associated genes in PND90 prostate tissues from rats with neonatal exposure to these xenoestrogens. Among 25 epigenetically regulated candidate genes, the promoter methylation status of 7 genes (<italic>Pitx3, Wnt10b, Paqr4, Sox2, Chst14, Tpd52, Creb3l4</italic>) was inversely correlated to gene expression. These validated genes have functional connectivity associated with stem cell pluripotency. Of clinical relevance, expression of these genes was found to be associated with recurrence-free survival of 497 patients in The Cancer Genome Atlas (TCGA) PCa cohort, suggesting that they may have utilities for predicting disease progression and patient stratification based on disease aggressiveness.</p></sec><sec sec-type="results" id="s0002"><title>Results</title><sec id="s0002-0001"><title>Methylation array revealed differential promoter methylation of genes associated with neonatal EB or BPA exposure in the PND90 prostate</title><p>We performed genome-wide methylation analysis, using MIRA-assisted genomic tiling and CpG island array, in dorsal prostate tissues from PND90 rats neonatally exposed to EB or BPA (<xref ref-type="fig" rid="f0001">Fig.&#x000a0;1</xref>). Using a 750&#x000a0;bp sliding window approach and a selection criteria of <italic>P</italic> &#x0003c; 10<sup>&#x02212;5</sup> and mBar &#x0003e;0.6 or &#x0003c;&#x02212;0.25 (<xref ref-type="fig" rid="f0001">Fig.&#x000a0;1</xref>), we identified a total of 177 differentially methylated regions (DMRs), which were randomly distributed among chromosomes (Supplemental Figure&#x000a0;S1). Since this array was designed to target CpG sites only at the gene promoter region, the genes described hereafter refer to those identified with DMRs at the 5&#x02032;-promoter region. Of the 177 genes with identified DMRs, 111 genes were EB-associated, 86 genes were BPA-associated, and 20 genes were common between the 2 groups (<xref ref-type="fig" rid="f0001">Fig.&#x000a0;1</xref>; Supplemental Table&#x000a0;S1).
<fig id="f0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Schematic diagram of the experimental and analytical procedures. Sprague-Dawley (SD) rats were neonatally [postnatal day (PND) 1, 3, 5] treated with 17&#x003b2;-estradiol-3-benzoate (EB) at 25&#x000a0;&#x003bc;g/pup or 2,500&#x000a0;&#x000b5;g/kg body weight (BW), bisphenol A (BPA) at 0.1&#x000a0;&#x000b5;g/pup or 10&#x000a0;&#x000b5;g/kg BW, or corn oil as a control (Ctrl). DNA extracted from PND90 dorsal prostate tissue was subjected to promoter methylation array analysis, and genes with differentially methylated regions and inverse expression correlation were identified and validated.</p></caption><graphic xlink:href="kepi-11-09-1208891-g001"/></fig>
</p></sec><sec id="s0002-0002"><title>Biological significance of differentially methylated regions associated with neonatal EB and BPA exposure in PND90 prostate</title><p>To identify biological processes related to the identified exposure-associated DMRs, we performed functional network analysis using Ingenuity Pathway Analysis (IPA). As shown in <xref ref-type="table" rid="t0001">Table&#x000a0;1</xref>, the top 3 networks related to the EB-associated genes were identified as: 1) &#x0201c;tissue morphology, embryonic development, organ development;&#x0201d; 2) &#x0201c;cell-to-cell signaling and interaction, cell-mediated immune response, cellular growth and proliferation;&#x0201d; and 3) &#x0201c;post-translational modification, cellular assembly and organization, cellular function and maintenance.&#x0201d; Upon merging the molecular interactions of these top 3 networks, the EB-associated genes were found to converge at protein kinase B (AKT) and extracellular-signal-regulated kinase (ERK)1/2. While the EB-associated genes had implications in the development and function of several physiological systems, including embryonic, tissue, organ, and reproductive (<xref ref-type="table" rid="t0001">Table&#x000a0;1</xref>), the top related disease was &#x0201c;cancer,&#x0201d; which included PCa.
<table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Top networks and bio-functions of the genes associated with neonatal 17&#x003b2;-estradiol-3-benzoate (EB) or bisphenol A (BPA) exposure in postnatal day (PND)90 prostate.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/></colgroup><thead><tr><th align="left">EB-associated genes</th><th align="left">BPA-associated genes</th></tr><tr><th align="left">Number of genes = 111</th><th align="left">Number of genes = 86</th></tr></thead><tbody><tr><td align="left">Top networks</td><td align="left">Top networks</td></tr><tr><td align="left">1. Tissue morphology, Embryonic development, Organ development</td><td align="left">1. Cell-to-cell signaling and interaction, Cell-mediated immune response, Cellular growth and proliferation</td></tr><tr><td align="left">2. Cell-to-cell signaling and interaction, Cell-mediated immune response, Cellular growth and proliferation</td><td align="left">2. Nucleic acid metabolism, Small molecule biochemistry, Molecular transport</td></tr><tr><td align="left">3. Post-translational modification, Cellular assembly and organization, Cellular function and maintenance</td><td align="left">3. Cellular assembly and organization, Cellular function and maintenance, Cellular compromise</td></tr><tr><td align="left">4. Molecular transport, Nucleic acid metabolism, Small molecule biochemistry</td><td align="left">4. Cell cycle, Cell-to-cell signaling and interaction, Cellular growth and proliferation</td></tr><tr><td align="left">5. Lipid metabolism, small molecule biochemistry, Endocrine system development and function</td><td align="left">5. Lipid metabolism, Molecular transport, Small molecule biochemistry</td></tr><tr><td colspan="2" align="left">&#x000a0;</td></tr><tr><td align="left">Top bio-functions</td><td align="left">Top bio-functions</td></tr><tr><td align="left">Diseases and disorders</td><td align="left">Diseases and disorders</td></tr><tr><td align="left">1. Cancer</td><td align="left">1. Antimicrobial response</td></tr><tr><td align="left">2. Reproductive system disease</td><td align="left">2. Cancer</td></tr><tr><td align="left">3. Metabolic disease</td><td align="left">3. Connective tissue disorders</td></tr><tr><td align="left">4. Auditory disease</td><td align="left">4. Developmental disorder</td></tr><tr><td align="left">5. Cardiovascular disease</td><td align="left">5. Gastrointestinal disease</td></tr><tr><td colspan="2" align="left">&#x000a0;</td></tr><tr><td align="left">Physiological system development and function</td><td align="left">Physiological system development and function</td></tr><tr><td align="left">1. Embryonic development</td><td align="left">1. Digestive system development and function</td></tr><tr><td align="left">2. Organ development</td><td align="left">2. Organ morphology</td></tr><tr><td align="left">3. Organismal development</td><td align="left">3. Cardiovascular system development and function</td></tr><tr><td align="left">4. Reproductive system development and function</td><td align="left">4. Organismal development</td></tr><tr><td align="left">5. Tissue development</td><td align="left">5. Tissue morphology</td></tr></tbody></table><table-wrap-foot><fn id="t1fn0001"><p>Data were analyzed using Qiagen's Ingenuity Pathway Analysis (IPA; Qiagen, <ext-link ext-link-type="uri" xlink:href="http://www.qiagen.com/ingenuity">www.qiagen.com/ingenuity</ext-link>).</p></fn></table-wrap-foot></table-wrap>
</p><p>Similarly, the top 3 networks related to the 86 BPA-associated genes were identified as: 1) &#x0201c;cell-to-cell signaling and interaction, cell-mediated immune response, cellular growth and proliferation;&#x0201d; 2) &#x0201c;nucleic acid metabolism, small molecule biochemistry, molecular transport;&#x0201d; and 3) &#x0201c;cellular assembly and organization, cellular function and maintenance, cellular compromise&#x0201d; (<xref ref-type="table" rid="t0001">Table&#x000a0;1</xref>). The molecular interactions of these networks converged at transforming growth factor &#x003b2; (TGF&#x003b2;), and the 86 genes had implications in digestive and cardiovascular system development and function, organ and tissue morphology, and organismal development (<xref ref-type="table" rid="t0001">Table&#x000a0;1</xref>). Like the EB-associated genes, BPA-associated genes were also highly associated with &#x0201c;cancer,&#x0201d; including PCa.</p><p>Interestingly, the top 3 networks related to the 20 associated genes common of both EB- and BPA-exposure were: 1) &#x0201c;cancer, organismal injury and abnormalities, renal and urological disease;&#x0201d; 2) &#x0201c;cell-to-cell signaling and interaction, nervous system development and function, cardiovascular disease;&#x0201d; and 3) &#x0201c;cancer, connective tissue disorders, dermatological diseases and conditions&#x0201d; (Supplemental Table&#x000a0;S2C). While these 3 networks converged at tumor protein 53 (TP53), overall, the 20 genes were significantly related to digestive, hepatic, and nervous system development and function, and embryonic and organismal development (Supplemental Table&#x000a0;S2). They also had implications in &#x0201c;connective tissue disorders,&#x0201d; &#x0201c;developmental disorder,&#x0201d; &#x0201c;hereditary disease,&#x0201d; &#x0201c;inflammatory disease,&#x0201d; and &#x0201c;metabolic disease&#x0201d; (Supplemental Table&#x000a0;S2).</p></sec><sec id="s0002-0003"><title>Selection of top candidate genes for methylation validation by bisulfite sequencing</title><p>To tighten the selection of differentially methylated candidate genes, we initially sorted the 177 identified genes based on <italic>P</italic> &#x0003c; 10<sup>&#x02212;10</sup> and mBar (EB/BPA &#x02013; Control) &#x02265;1 .5 or &#x02264;&#x02212;0.5 (Selection criteria A, <xref ref-type="fig" rid="f0001">Fig.&#x000a0;1</xref>). Under this stringent selection criteria, 20 candidate genes were identified (Supplemental Table&#x000a0;S3), of which the top 9 most differentially methylated genes, based on differences in mBar values (<xref ref-type="fig" rid="f0002">Fig.&#x000a0;2</xref>), across exposure groups (<italic>Btbd3, Chst14, Creb3l4, Paqr4, Phpt1, Rbpjl, Sox2, Tacstd2</italic>, and <italic>Tpd52</italic>) were selected for validation. As shown in <xref ref-type="fig" rid="f0002">Figure&#x000a0;2</xref>, primers for bisulfite sequencing validation for each gene were designed to amplify the region with the greatest methylation changes between the EB/BPA-treated groups and the control group. In most cases, the interrogated regions were closely aligned to the predicted CpG island based on MethPrimer program.<xref rid="cit0037" ref-type="bibr"><sup>37</sup></xref>
<fig id="f0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Representative results from genome-wide methylation study. A) Predicted CpG islands (light blue shaded areas) in the promoter region of differentially methylated genes (<italic>Pitx3, Wnt10b, Paqr4, Sox2, Chst14, Tpd52</italic>, and <italic>Creb3l4</italic>) identified in this study. TSS stands for transcriptional start site whereas ATG stands for translational start codon. Individual CpG sites are represented by red vertical lines. Dark blue horizontal line marks the region selected for BS-sequencing; B) Position of the BS-sequenced region (blue line) relative to the NimbleGen probes covered regions (dirty yellow lines) of each gene; C) Significant methylation level of each gene in vehicle- (control), EB- and BPA-treated groups, which were measured by NimbleGen array probes (mBar values). The height of the mBar represents the probe intensity; red and green bars represent positive and negative methylation value, respectively, relative to their respective input control.</p></caption><graphic xlink:href="kepi-11-09-1208891-g002"/></fig>
</p><p>Promoter methylation status was validated by performing bisulfite sequencing analysis on the same PND90 prostate tissue samples used in the methylation array (<xref ref-type="table" rid="t0002">Table&#x000a0;2</xref>; Supplemental Table&#x000a0;S3). In accordance with the methylation patterns observed in the array, the DMRs of 7 out of 9 genes were confirmed. The DMRs of <italic>Chst14, Paqr4, Phpt1, Rbpjl</italic>, and <italic>Sox2</italic> were hypomethylated, while those of <italic>Creb3l4</italic> and <italic>Tpd52</italic> were hypermethylated in the EB/BPA-exposure groups when compared to controls (<xref ref-type="table" rid="t0002">Table&#x000a0;2</xref>).
<table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Validation of promoter methylation status and gene expression in postnatal day (PND)90 prostate.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th colspan="2" align="center">Selection criteria<xref rid="t2fn0001" ref-type="fn"><sup>#</sup></xref><hr/></th><th colspan="2" align="center">Validated in EB and/BPA<hr/></th><th align="center">&#x000a0;</th></tr><tr><th align="center">Gene</th><th align="center">A</th><th align="center">B</th><th align="center">Methylation<xref rid="t2fn0003" ref-type="fn"><sup>a</sup></xref></th><th align="center">Expression<xref rid="t2fn0004" ref-type="fn"><sup>b</sup></xref></th><th align="center">Gene name</th></tr></thead><tbody><tr><td align="left">Acrbp</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hyper</td><td align="left">&#x000a0;</td><td align="left">Acrosine binding protein</td></tr><tr><td align="left">Btbd3</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">BTB domain containing protein 3</td></tr><tr><td align="left">Ccdc67</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Coiled-coil domain containing protein 67</td></tr><tr><td align="left">Chad</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hyper</td><td align="left">&#x000a0;</td><td align="left">Chondroadherin</td></tr><tr><td align="left">Chst14</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">Hypo</td><td align="center">&#x02191;</td><td align="left">Carbohydrate sulfotransferase 14</td></tr><tr><td align="left">Creb3l4</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">Hyper</td><td align="center">&#x02193;</td><td align="left">cAMP responsive element binding protein 3-like 4</td></tr><tr><td align="left">Dnase2b</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Deoxyribonuclease II beta</td></tr><tr><td align="left">Habp2</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Hyaluronan binding protein 2/FSAP</td></tr><tr><td align="left">Krt83</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Keratin 83</td></tr><tr><td align="left">Nfia</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Nuclear factor I/A</td></tr><tr><td align="left">Osbpl6</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hyper</td><td align="left">&#x000a0;</td><td align="left">Oxysterol binding protein-like 6</td></tr><tr><td align="left">Paqr4</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">Hypo</td><td align="center">&#x02191;</td><td align="left">Progestin and adipoQ receptor family member 4</td></tr><tr><td align="left">Phpt1</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">Hypo</td><td align="left">&#x000a0;</td><td align="left">Phosphoshistidine phosphatase 1</td></tr><tr><td align="left">Pitx3</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hypo</td><td align="center">&#x02191;</td><td align="left">Paired-like homeodomain 3</td></tr><tr><td align="left">Prkar1a</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Protein kinase cAMP-dependent type 1 regulatory subunit alpha</td></tr><tr><td align="left">Rbpjl</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">Hypo</td><td align="left">&#x000a0;</td><td align="left">Recombination signal binding protein for immunoglobulin kappa J region-like</td></tr><tr><td align="left">Rnf186</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hyper</td><td align="left">&#x000a0;</td><td align="left">Ring finger protein 186</td></tr><tr><td align="left">Sox2</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">Hypo</td><td align="center">&#x02191;</td><td align="left">Sex determining region Y box 2</td></tr><tr><td align="left">Tacstd2</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Tumor-associated calcium signal transducer 2</td></tr><tr><td align="left">Tbx4</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">T-box 4</td></tr><tr><td align="left">Tmem27</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hyper</td><td align="left">&#x000a0;</td><td align="left">Transmembrane protein 27</td></tr><tr><td align="left">Tpd52</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">Hyper</td><td align="center">&#x02193;</td><td align="left">Tumor protein D52</td></tr><tr><td align="left">Tymp</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hyper</td><td align="left">&#x000a0;</td><td align="left">Thymidine phosphorylase</td></tr><tr><td align="left">Uox</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Urate oxidase</td></tr><tr><td align="left">Wnt10b</td><td align="left">&#x000a0;</td><td align="center">&#x0221a;</td><td align="left">Hypo</td><td align="center">&#x02191;</td><td align="left">Wingless-type MMTV integration site family, member 10B</td></tr></tbody></table><table-wrap-foot><fn id="t2fn0001"><label>#</label><p>Selection criteria used for identifying genes with differential promoter DMR methylation in PND90 prostate of rats neonatally exposed to 17&#x003b2;-estradiol-3-benzoate (EB) or bisphenol A (BPA) vs. control group</p></fn><fn id="t2fn0002"><p>Selection criteria A: <italic>P</italic> &#x0003c; 10<sup>&#x02212;10</sup> and mBar (EB/BPA - Control) &#x02265;1.5 or &#x02264;&#x02212;0.5; Selection criteria B: <italic>P</italic> &#x0003c; 10<sup>&#x02212;5</sup> and mBar (EB/BPA - Control) &#x02265;1.2 or &#x02264;&#x02212;0.5.</p></fn><fn id="t2fn0003"><label>a</label><p>Promoter methylation validated by bisulfite sequencing: Hyper=hypermethylated; Hypo=hypomethylated</p></fn><fn id="t2fn0004"><label>b</label><p>Gene expression validated by qPCR analysis: &#x02191; = up-regulated and &#x02193; = downregulated</p></fn><fn id="t2fn0005"><p>Highlighted in light grey, genes with promoter methylation status validated</p></fn><fn id="t2fn0006"><p>Highlighted in dark grey, genes with promoter methylation status and gene expression validated to be inversely correlated.</p></fn></table-wrap-foot></table-wrap>
</p><p>To include more genes in the analysis, we also sorted the 177 exposure-associated genes using wider selection parameters of <italic>P</italic> &#x0003c; 10<sup>&#x02212;5</sup> and mBar (EB/BPA &#x02013; Control) &#x02265;1.2 or &#x02264;&#x02212;0.5 (Selection criteria B, <xref ref-type="fig" rid="f0001">Fig.&#x000a0;1</xref>). Using selection criteria B, 91 candidate genes were identified (Supplemental Table&#x000a0;S4). Bisulfite sequencing analysis was performed on the top 16 most differentially methylated genes across exposure groups (<italic>Acrbp, Ccdc67, Chad, Dnase2b, Habp2, Krt83, Nfia, Osbp16, Pitx3, Prkar1a, Rnf186, Tbx4, Tmem27, Tymp, Uox</italic>, and <italic>Wnt10b</italic>) (<xref ref-type="table" rid="t0002">Table&#x000a0;2</xref>; Supplemental Table&#x000a0;S4). Promoter methylation validation of the 16 genes, using PND90 dorsal prostate tissues, confirmed promoter hypomethylation of <italic>Pitx3</italic> and <italic>Wnt10b</italic>, and promoter hypermethylation of <italic>Acrbp, Chad, Osbp16, Rnf186, Tmem27</italic>, and <italic>Tymp</italic> (<xref ref-type="table" rid="t0002">Table&#x000a0;2</xref>).</p><p>Overall, using 2 selection criteria, there were 25 top differentially methylated candidate genes identified, of which the promoter methylation status of 15 were validated (<italic>Chst14, Creb3l4, Paqr4, Phpt1, Rbpjl, Sox2</italic>, and <italic>Tpd52</italic> from selection criteria A; and <italic>Acrbp, Chad, Osbp16, Pitx3, Rnf186, Tmem27, Tymp</italic>, and <italic>Wnt10b</italic> from selection criteria B) (<xref ref-type="table" rid="t0002">Table&#x000a0;2</xref>).</p></sec><sec id="s0002-0004"><title>Validation of promoter methylation status and gene expression correlation</title><p>To elucidate the biological relevance of the DMRs within these gene promoters, we next performed gene expression analyses on the PND90 prostate tissues. As shown in <xref ref-type="fig" rid="f0003">Figure&#x000a0;3</xref>, expression of <italic>Pitx3, Wnt10b, Paqr4, Sox2</italic>, and <italic>Chst14</italic> was significantly upregulated in the EB-exposure group when compared to the control. Of these genes, only <italic>Sox2</italic> was significantly upregulated in the BPA-exposure vs. control group. In contrast, expression of <italic>Tpd52</italic> was significantly downregulated in both exposure groups, and <italic>Creb3l4</italic> showed a trend of downregulation in exposure groups, when compared to the control group (<xref ref-type="fig" rid="f0003">Fig.&#x000a0;3</xref>). Since gene expression of <italic>Acrbp, Chad, Osbp16, Rnf186, Tmem27</italic>, and <italic>Tymp</italic> in the prostate tissues of the exposure groups did not associate with their validated promoter methylation status, they were not studied further (<xref ref-type="table" rid="t0002">Table&#x000a0;2</xref>; data not shown).
<fig id="f0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Effect of neonatal exposure to EB or BPA on promoter methylation and gene expression in PND90 dorsal prostate. Promoter methylation status (left panel: Scatter Plot) and expression (right panel: Bar Graph) of candidate genes, in PND90 prostate tissues from SD rats treated with either corn oil (Ctrl; white), EB (green), or BPA (red), were analyzed using bisulfite sequencing and qPCR, respectively. Each circle in the scatter plot represents mean &#x000b1;SEM of methylation percentage (averaged from 6 individual samples/animals) at a single CpG site in the gene promoter region. The % methylation of each CpG site in each sample was determined from bisulfite sequencing data derived from 8&#x02013;12 clones. Gene expression data were expressed as mean &#x000b1; SEM from 3 individual samples. Statistical significance was determined by one-way ANOVA and Tukey test when compared to Ctrl. *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, and ***<italic>P</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="kepi-11-09-1208891-g003"/></fig>
</p><p>To investigate the collective biological relevance of the 7 candidate genes (<italic>Pitx3, Wnt10b, Paqr4, Sox2, Chst14, Tpd52</italic>, and <italic>Creb3l4</italic>), we performed functional network analysis using IPA. We found that the candidate genes were associated with 2 networks: 1) &#x0201c;embryonic development, organismal development, gene expression&#x0201d; and 2) &#x0201c;cell cycle, embryonic development, gene expression&#x0201d; (Supplemental Table&#x000a0;S5), which converged at <italic>Sox2</italic> (<xref ref-type="fig" rid="f0004">Fig.&#x000a0;4</xref>). While these 7 candidate genes had implications in embryonic, organ, and organismal development, as well as auditory, vestibular, and nervous system development and function, &#x0201c;cancer&#x0201d; was determined to be the top-related disease associated with the differentially methylated genes with inverse expression correlation (Supplemental Table&#x000a0;S5). Complementary reported bio-functions are summarized in <xref ref-type="table" rid="t0003">Table&#x000a0;3</xref>.
<fig id="f0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Signaling pathways associated with differentially methylated candidate genes were predicted by Ingenuity Pathway Analysis&#x02122;. Genes with promoter hypermethylation are shown in red and genes with promoter hypomethylation are shown in green, with color intensity signifying the magnitude of differential methylation. Gray arrows indicate predicted association pathways; purple arrows indicate reported directional pathways.</p></caption><graphic xlink:href="kepi-11-09-1208891-g004"/></fig>
<table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Reported bio-function(s) and PCa associations of the seven identified candidate genes with DMRs inversely correlated with gene expression as a result of neonatal 17&#x003b2;-estradiol-3-benzoate/bisphenol A (EB/BPA) exposure.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th colspan="2" align="center">Promoter methylation<hr/></th><th colspan="2" align="center">Gene expression<hr/></th><th align="center">&#x000a0;</th><th align="center">&#x000a0;</th><th align="center">&#x000a0;</th><th align="center">&#x000a0;</th></tr><tr><th align="left">Gene</th><th align="center">EB<xref rid="t3fn0001" ref-type="fn"><sup>a</sup></xref></th><th align="center">BPA<xref rid="t3fn0002" ref-type="fn"><sup>b</sup></xref></th><th align="center">EB<xref rid="t3fn0001" ref-type="fn"><sup>a</sup></xref></th><th align="center">BPA<xref rid="t3fn0002" ref-type="fn"><sup>b</sup></xref></th><th align="center">Reported bio-function(s)</th><th align="center">Gene expression in PCa</th><th align="center">Other pathological diseases</th><th align="center">Reported stem/progenitor cell bio-function</th></tr></thead><tbody><tr><td align="left">Pitx3</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="left">Knockdown of Pitx3 promoted the loss of lens epithelial cells by inducing early activation of cell cycle inhibitors<xref ref-type="bibr" rid="cit0071"><sup>71</sup></xref></td><td align="left">Not reported</td><td align="left">Downregulated in Chinese patients with Parkinson's disease<xref ref-type="bibr" rid="cit0072"><sup>72</sup></xref></td><td align="left">Expression of Pitx3 initiated differentiation of mid-brain derived neural stem cells<xref ref-type="bibr" rid="cit0073"><sup>73</sup></xref></td></tr><tr><td align="left">Wnt10b</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="left">Upregulating Wnt10b expression in endometrial cells Ishikawa increased cell proliferation and reduced apoptosis<xref ref-type="bibr" rid="cit0074"><sup>74</sup></xref><break/>Overexpression of Wnt10b in dermal papilla cells increased cell proliferation<xref ref-type="bibr" rid="cit0075"><sup>75</sup></xref><break/>Overexpression of Wnt10b induced S-phase cell progression in mouse mammary epithelial and human BCa cells<xref ref-type="bibr" rid="cit0050"><sup>50</sup></xref><break/>Overexpression of WNT10B in TNBC increased cell proliferation by upregulating oncogene high mobility group A hook-2.<xref ref-type="bibr" rid="cit0076"><sup>76</sup></xref></td><td align="left">Upregulated in prostate tumors when compared to normal prostate tissues<xref ref-type="bibr" rid="cit0057"><sup>57</sup></xref><break/>Upregulated in prostate tumors in a stage-dependent manner<xref ref-type="bibr" rid="cit0077"><sup>77</sup></xref></td><td align="left">Upregulation is associated with poor survival of patients with osteosarcoma<xref ref-type="bibr" rid="cit0005"><sup>5</sup></xref><break/>Upregulated in endometrial cancer tissues when compared to hyperplastic or normal tissue samples<xref ref-type="bibr" rid="cit0074"><sup>74</sup></xref></td><td align="left">Treatment of human embryonic stem cell colony culture induces the formation of prostate organoids<xref ref-type="bibr" rid="cit0078"><sup>78</sup></xref><break/>Wnt10b conditioned medium promoted proliferation, morphological changes, and chemotaxis of immortalized and primary mouse spermatogonial stem cells<xref ref-type="bibr" rid="cit0079"><sup>79</sup></xref></td></tr><tr><td align="left">Paqr4</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="left">Not reported</td><td align="left">Not reported</td><td align="left">Pancreatic cancer<xref ref-type="bibr" rid="cit0080"><sup>80</sup></xref></td><td align="left">Not reported</td></tr><tr><td align="left">Sox2</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">Overexpression of Sox2 in DU145 increased cell migration and proliferation, reduced apoptosis,<xref ref-type="bibr" rid="cit0051 cit0052"><sup>51,52</sup></xref> and promoted tumorigenesis<xref ref-type="bibr" rid="cit0048"><sup>48</sup></xref><break/>Conditional Sox2 deletion in pre-existing skin papilloma and skin squamous-cell carcinoma (SCC) reduced tumor growth and cancer cell propagation in serial transplantation<xref ref-type="bibr" rid="cit0081"><sup>81</sup></xref><break/>Overexpression of Sox2 in chick embryos inhibited neural differentiation<xref ref-type="bibr" rid="cit0082"><sup>82</sup></xref></td><td align="left">Upregulated in PCa<xref ref-type="bibr" rid="cit0083"><sup>83</sup></xref><break/>Upregulated in PCa with higher Gleason score<xref ref-type="bibr" rid="cit0048 cit0049"><sup>48,49</sup></xref></td><td align="left">Downregulated in colon cancer<xref ref-type="bibr" rid="cit0084"><sup>84</sup></xref> and gastric cancer<xref ref-type="bibr" rid="cit0007"><sup>7</sup></xref><break/>Upregulated in squamous cell lung cancer<xref ref-type="bibr" rid="cit0085"><sup>85</sup></xref>, SCC<xref ref-type="bibr" rid="cit0081"><sup>81</sup></xref> nasopharyngeal carcinoma<xref ref-type="bibr" rid="cit0086"><sup>86</sup></xref>, and <break/>Frequently expressed in basal-like breast cancer tumors when compared to luminal and HER2+ tumors<xref ref-type="bibr" rid="cit0087"><sup>87</sup></xref></td><td align="left">Overexpression of Sox2 protein in mouse embryonic stem (ES) cells trigger their differentiation into cells that express markers for various differentiated cell types<xref ref-type="bibr" rid="cit0088"><sup>88</sup></xref><break/>Overexpression of Sox2 suppresses neural differentiation through downregulating GFAP expression<xref ref-type="bibr" rid="cit0004"><sup>4</sup></xref>.<break/>Sox2 expression maintains osteoblast self-renewal<xref ref-type="bibr" rid="cit0089"><sup>89</sup></xref><break/>Deletion of Sox2 in neural stem cells (NSC) reduced the size and formation of neurospheres<xref ref-type="bibr" rid="cit0090"><sup>90</sup></xref><break/>Inhibiting Sox2 signaling decreased progenitor marker expression and promoted neuronal differentiation<xref ref-type="bibr" rid="cit0082"><sup>82</sup></xref></td></tr><tr><td align="left">Chst14</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="left">Loss of Chst14 in neuronal stem cells reduce cell proliferation<xref ref-type="bibr" rid="cit0091"><sup>91</sup></xref></td><td align="left">Not reported</td><td align="left">Downregulated in colorectal cancer<xref ref-type="bibr" rid="cit0084"><sup>84</sup></xref></td><td align="left">Loss of Chst14 decreased neurogenesis and proliferation of neural stem cells<xref ref-type="bibr" rid="cit0091"><sup>91</sup></xref></td></tr><tr><td align="left">Tpd52</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">Overexpression of TPD52 increased LNCaP cell proliferation and migration<xref ref-type="bibr" rid="cit0052"><sup>52</sup></xref><break/>Mice inoculated with TPD52 overexpressing fibroblasts have been shown to develop lung metastasis<xref ref-type="bibr" rid="cit0092"><sup>92</sup></xref></td><td align="left">Upregulated in high-grade PIN<xref ref-type="bibr" rid="cit0053 cit0093"><sup>53,93</sup></xref> and PCa<xref ref-type="bibr" rid="cit0052 cit0053 cit0054"><sup>52-54</sup></xref><break/>Higher expression in Gleason score 4 than 3 prostate tumors,<xref ref-type="bibr" rid="cit0093"><sup>93</sup></xref> in localized PCa with Gleason score 4+4=8 than 3+3=6 localized PCa<xref ref-type="bibr" rid="cit0094"><sup>94</sup></xref>, and in hormone na&#x000ef;ve and refractory metastatic PCa<xref ref-type="bibr" rid="cit0095"><sup>95</sup></xref></td><td align="left">Upregulated in ovarian cancer<xref ref-type="bibr" rid="cit0096"><sup>96</sup></xref><break/>Upregulated in testicular germ cell tumors<xref ref-type="bibr" rid="cit0097"><sup>97</sup></xref></td><td align="left">Higher expression in the earlier passages of differentiating human dental pulp stem cells<xref ref-type="bibr" rid="cit0098"><sup>98</sup></xref></td></tr><tr><td align="left">Creb3l4</td><td align="center"><xref rid="t3fn0003" ref-type="fn"><sup>*</sup></xref></td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Overexpression of Creb3l4 in LNCaP cells upregulated genes related to PCa<xref ref-type="bibr" rid="cit0099"><sup>99</sup></xref>.</td><td align="left">Upregulated in PCa when compared to adjacent normal tissues<xref ref-type="bibr" rid="cit0055"><sup>55,56</sup></xref></td><td align="left">Not reported</td><td align="left">Loss of Creb3l4 increased apoptosis of meiotic/post-meiotic germ cells in the mouse seminiferous tubules<xref ref-type="bibr" rid="cit0100"><sup>100</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="t3fn0001"><label>a</label><p>Treatment with 2,500&#x000a0;&#x000b5;g EB/kg BW/day on PND1, 3, and 5.</p></fn><fn id="t3fn0002"><label>b</label><p>Treatment with 10&#x000a0;&#x000b5;g BPA/kg BW/day on PND1, 3, and 5.</p></fn><fn id="t3fn0003"><label>*</label><p>indicates a statistically significant change (<italic>P</italic> &#x0003c; 0.05) in promoter DMR methylation (validated by bisulfite sequencing) or gene expression (validated by qPCR) between treatment and control groups</p></fn><fn id="t3fn0004"><p>Light grey, promoter hypomethylation or decreased gene expression; dark grey, promoter hypermethylation or increased gene expression</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0002-0005"><title>Effect of 5-aza-cytidine on the expression of differential methylation candidate genes in rat prostate cells</title><p>To determine whether the expression of the 7 identified candidate genes (<italic>Pitx3, Wnt10b, Paqr4, Sox2, Chst14, Tpd5</italic>, and <italic>Creb3l4</italic>) were directly regulated by DNA methylation, we compared gene expression in a rat prostate epithelial cell line NbE-1 <xref rid="cit0038" ref-type="bibr"><sup>38</sup></xref> and the rat PCa cell line AIT<xref rid="cit0039" ref-type="bibr"><sup>39</sup></xref>, either with or without a 4-day treatment of the DNA methylation inhibitor, 5-aza-cytidine (5-aza) at doses of 0.5&#x000a0;&#x000b5;M and 1&#x000a0;&#x000b5;M. When compared to the untreated control, 5-aza treatment significantly upregulated <italic>Pitx3, Wnt10b, Chst14</italic>, and <italic>Creb3l4</italic> in NbE-1 cells, and <italic>Pitx3, Wnt10b, Sox2, Chst14, Tpd52</italic>, and <italic>Creb3l4</italic> in AIT cells (<xref ref-type="fig" rid="f0005">Fig.&#x000a0;5</xref>). Although the same treatment increased the expression of <italic>Sox2</italic> and <italic>Tpd52</italic> in NbE-1 cells, the change was not significant. Overall, the 5-aza treatment had no effect on the expression of <italic>Paqr4</italic> in both NbE-1 and AIT cells.
<fig id="f0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Effect of 5-aza-cytidine treatment on gene expression in NbE-1 and AIT cells. Gene expression was analyzed by qPCR in rat (A) normal prostate epithelial NbE-1 cells and (B) prostate cancer AIT cells treated with DMSO (Ctrl), or 0.5&#x000a0;&#x000b5;M or 1&#x000a0;&#x000b5;M 5-aza-2-deoxycytidine (5-aza), a DNA methylation inhibitor, for 8 d. Data (mean &#x000b1; SEM ) is normalized to corresponding <italic>Rpl19</italic> levels, and is expressed as fold change vs. Ctrl. *<italic>P</italic> &#x0003c; 0.05, and **<italic>P</italic> &#x0003c; 0.001 by one-way ANOVA and Tukey test when compared to Ctrl.</p></caption><graphic xlink:href="kepi-11-09-1208891-g005"/></fig>
</p></sec><sec id="s0002-0006"><title>Association of the identified candidate genes with the recurrence of PCa</title><p>To gain clinical significance, RNAseq data from 497 PCa specimens and their associated clinical data (Biotab) were retrieved from the TCGA database. Extensive data transformation and biostatistical analyses revealed that the expression of these 7 genes in human PCa samples correlated with recurrence-free survival, i.e., the cohort of patients was segregated into those with longer (Group 1) and shorter (Group 2) duration to cancer re-appearance after initial treatment. For the initial 5-year survival after diagnosis, Group 2 patients had a shorter time to recurrence (poorer recurrence-free survival) when compared with Group 1 (<xref ref-type="fig" rid="f0006">Fig.&#x000a0;6A</xref>, Hazard ratio = 1.786, log rank test <italic>P</italic> = 0.0411), suggesting Group 2 had significantly more aggressive disease. Consistent with this finding, we found that Group 2 had significantly more cases with higher tumor Gleason score (&#x02265;7) when compared with Group 1 (Odds ratio = 0.3423; <italic>P</italic> &#x0003c; 0.0001) (<xref ref-type="fig" rid="f0006">Fig.&#x000a0;6B</xref>). It is well established that men with higher grade tumors have higher risk of dying from PCa.<xref rid="cit0040" ref-type="bibr"><sup>40</sup></xref>
<fig id="f0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Expression of the 7 candidate genes was associated with shorter recurrence-free survival of PCa patients. TCGA data consisting of 497 PCa patients were dichotomized into Groups 1 and 2 by K-means clustering analysis based on the 7 candidate genes. (A) Group 1 patients have longer time to recurrence than Group 2 patients; the two groups differ in recurrence-free survival. (B) Proportion of PCa patients having tumors with high (&#x02265;7) and low (&#x0003c;7) Gleason score.</p></caption><graphic xlink:href="kepi-11-09-1208891-g006"/></fig>
</p></sec></sec><sec sec-type="discussion" id="s0003"><title>Discussion</title><p>In the present study, we conducted a comprehensive genome-wide search for DNA methylation targets of developmental exposure to EB and BPA, with a view to identifying candidate epigenetic biomarkers for predicting PCa risk. We reported the genome-wide promoter methylation changes in PND90 dorsal prostate tissues related to neonatal exposure to EB or BPA. Overall, we identified 111 EB-associated and 86 BPA-associated DMRs, with 20 in common between the 2 groups. Using two selection criteria, 25 candidate genes were selected, of which 15 were validated to have treatment-associated promoter methylation changes using bisulfite sequencing analysis, and 7 identified to exhibit an inverse correlation between promoter methylation status and gene expression. EB treatment upregulated the expression of <italic>Pitx3, Wnt10b, Paqr4, Sox2</italic>, and <italic>Chst14</italic> through promoter hypomethylation, and downregulated <italic>Tpd52</italic>, and <italic>Creb3l4</italic> through promoter hypermethylation. Similarly, BPA treatment upregulated <italic>Sox2</italic> and <italic>Chst14</italic> through promoter hypomethylation, and downregulated <italic>Tpd52</italic> through promoter hypermethylation, but had no significant effects on the other genes. Of the 7 candidate genes identified in the rat, <italic>WNT10b, SOX2, TPD52</italic>, and <italic>CREB3L4</italic> were upregulated in PCa (<xref ref-type="table" rid="t0003">Table&#x000a0;3</xref>), and <italic>PAQR4, WNT10b, PITX3</italic>, and <italic>TPD52</italic> were differentially methylated between PCa and adjacent normal prostate tissues.<xref rid="cit0069" ref-type="bibr"><sup>69</sup></xref> Clustering analysis, based on the expression of these 7 genes in PCa tissues of 497 PCa patients from the TCGA data sets, further revealed an association with shorter recurrence-free survival. Taken together, DNA methylation-mediated dysregulation of this unique signature of 7 genes established a causal link between early-life EDC exposure and PCa risk, and raises the possibility that such exposure may impact the human disease.</p><p>Neonatal development is a susceptible window for the DNA methylation reprogramming effects of EDCs. Since the prostate is estrogen responsive, it is highly vulnerable to insult by estrogenic agents during development.<xref rid="cit0027" ref-type="bibr"><sup>27,34,41</sup></xref> Using a neonatal EB/BPA exposure rat model, we previously reported that treatment-associated dysregulation of <italic>Pde4d4, Hmgn5</italic>, and <italic>Hpcal1</italic> through promoter methylation changes, persisted in the prostate throughout life.<xref rid="cit0025" ref-type="bibr"><sup>25,32</sup></xref> While we observed an increase in the incidence and severity of PIN in PND200 rats upon E<sub>2</sub>-induced carcinogenesis,<xref rid="cit0025" ref-type="bibr"><sup>25,32</sup></xref> the current study aimed to interrogate the underlying mechanism for the early-life EDC exposure-associated increase in PCa risk, by performing genome-wide promoter methylation analysis on PND90 prostate tissue. The 111 EB- and 86 BPA-associated genes with identified DMRs were mostly related to cell-to-cell signaling and interaction, cell-mediated immune response, and cellular growth and proliferation, with cancer as the major disease outcome. Specifically, most of these treatment-associated genes were related to 2 oncogenic rapid signaling molecules AKT and ERK1/2. AKT is upregulated in prostate tumors when compared to benign prostatic tissues<xref rid="cit0042" ref-type="bibr"><sup>42,43</sup></xref> and is associated with a stage-dependent increase in tumor cell proliferation.<xref rid="cit0044" ref-type="bibr"><sup>44</sup></xref> Its activation has also been shown to suppress androgen/androgen-receptor induced apoptosis in PC3 cells.<xref rid="cit0045" ref-type="bibr"><sup>45</sup></xref> Unlike AKT, expression of ERK1/2 is similar between PCa and normal tissues, yet its activation is associated with increased cell proliferation in PCa tissues.<xref rid="cit0046" ref-type="bibr"><sup>46</sup></xref> Moreover, the concomitant activation of Akt and Erk1/2 promotes PCa cell growth and tumorigenicity in a rodent PCa model.<xref rid="cit0047" ref-type="bibr"><sup>47</sup></xref> Taken together, these reports suggest a possible role for the identified treatment-associated genes in the malignant transformation of rat prostate epithelial cells.</p><p>Interestingly, functional connectivity of the 7 candidate genes was linked to embryonic stem cell pluripotency, further evidenced by convergence at <italic>Sox2</italic>. SOX2 is a stem cell marker upregulated in PCa.<xref rid="cit0048" ref-type="bibr"><sup>48-50</sup></xref> Overexpression of <italic>SOX2</italic> in human DU145 PCa cells promotes tumorigenesis,<xref rid="cit0048" ref-type="bibr"><sup>48</sup></xref> increases cell proliferation and migration, and reduces apoptosis.<xref rid="cit0051" ref-type="bibr"><sup>51,52</sup></xref> Of the other identified genes, <italic>TPD52</italic>, an oncogene, has been reported to be upregulated in high-grade PIN<xref rid="cit0033" ref-type="bibr"><sup>33,53</sup></xref> and PCa.<xref rid="cit0052" ref-type="bibr"><sup>52-54</sup></xref>
<italic>CREB3L4</italic><xref rid="cit0055" ref-type="bibr"><sup>55,56</sup></xref> and <italic>WNT10B</italic><xref rid="cit0057" ref-type="bibr"><sup>57</sup></xref> have also been found to be upregulated in prostate tumors. On the contrary, the expression of <italic>PITX3</italic> and <italic>CHST14</italic> has yet to be studied in PCa tissues. While only 4 of the 7 genes have been functionally characterized in PCa cells and tissues, all genes, except <italic>PAQR4</italic>, are related to stem cell proliferation, cancer cell proliferation migration, and/or tumorigenesis (reported bio-functions are summarized in <xref ref-type="table" rid="t0003">Table&#x000a0;3</xref>).</p><p>We have previously shown that prostate stem/progenitor cells isolated from the human adult prostate are more proliferative and able to retain their &#x0201c;stemness&#x0201d; properties when treated with E<sub>2</sub> or BPA.<xref rid="cit0017" ref-type="bibr"><sup>17,19</sup></xref> Suppression of a class of non-coding RNAs, the small nucleolar RNA C/D box,<xref rid="cit0030" ref-type="bibr"><sup>30</sup></xref> associated with distinct histone modifications<xref rid="cit0019" ref-type="bibr"><sup>19,30</sup></xref> has been postulated as a mechanism causing a slow-down in biosynthesis and stem cell differentiation, thus extending the proliferation phase of these cells. In concordance, our current study showed that neonatal exposure to xenoestrogens led to the dysregulation of a panel of stem cell function-related genes through DNA methylation in the adult prostate, lending further credence to this hypothesis. In this regard, neonatal exposure to xenoestrogens may allow for an extended proliferation phase and increase the number of stem/progenitor cells in the prostate. As such, these cells are known targets for carcinogen-induced malignant transformation in adult-life, leading to increased cancer susceptibility.<xref rid="cit0058" ref-type="bibr"><sup>58</sup></xref></p><p>In addition to their reported involvement in PCa, of clinical relevance, we report here that the expression of the novel 7-gene set is associated with shorter recurrence-free survival of PCa patients in the TCGA cohort. These patients were also mostly diagnosed with prostate tumors of high Gleason score (&#x02265;7). Of interest, we also found that 4 out of these 7 genes were differentially methylated between PCa tissues and their adjacent normal tissues in the cohort reported by Kim et&#x000a0;al.<xref rid="cit0059" ref-type="bibr"><sup>59</sup></xref> Thus, this gene signature may have diagnostic/prognostic value by serving as biomarkers for predicting disease initiation and progression.</p><p>Although neonatal exposure to either EB or BPA increased PCa risk in the rodent model, their DNA methylation mediated effects on the prostate are different. There were more EB-associated than BPA-associated genes identified from our promoter methylation array. Genes with methylation changes validated were also mostly EB-associated. Moreover, the EB-associated genes linked to AKT and ERK1/2 as the major signaling molecules, whereas the BPA-associated genes linked to TGF&#x003b2;, an oncogenic molecule upregulated in PCa.<xref rid="cit0060" ref-type="bibr"><sup>60</sup></xref> This indicates that they activate different signaling pathways to increase PCa risk. Furthermore, EB-treatment dysregulated <italic>Pitx3, Wnt10b, Paqr4</italic>, and <italic>Creb3l4</italic> in PND90 prostate tissues through promoter methylation changes, but BPA exposure had no significant effects. This suggests that EB had a stronger effect on the prostate than BPA, which could in part be related to a markedly higher dose of EB utilized (2500&#x000a0;&#x000b5;g/kg BW) when compared to the lower environmentally relevant dose of BPA (10&#x000a0;&#x000b5;g/kg BW). Alternatively, it has been reported that the action of BPA can be independent of the classical estrogen receptors (ER&#x003b1; and ER&#x003b2;) and mediated via estrogen-related receptor &#x003b3; (ERR&#x003b3;) and G protein-coupled receptor 30 (GPER1), to name a few.<xref rid="cit0061" ref-type="bibr"><sup>61,62</sup></xref> However, this does not explain why the expression of <italic>Acrbp, Chad, Osbpl6, Phpt1</italic>, and <italic>Tmem27</italic> did not correlate to their confirmed promoter methylation status, nor why the expression of <italic>Paqr4</italic> was unaffected by 5-aza treatment in NbE-1 and AIT cells. In human prostaspheres, E<sub>2</sub>/BPA-mediated small nucleolar RNA box C/D suppression was shown to be associated with the occupancy of histone marks the trimethylated histone 3 at lysine 9 and lysine 27, and the loss of trimethylated histone 3 at lysine 4, rather than DNA methylation.<xref rid="cit0030" ref-type="bibr"><sup>30</sup></xref> Thus, EB and BPA may dynamically alter the PND90 prostate transcriptome through other epigenetic mechanisms not yet explored.</p><p>In summary, we have identified a set of 7 genes (<italic>Pitx3, Wnt10b, Paqr4, Sox2, Chst14</italic>, and <italic>Tpd52</italic>, and <italic>Creb3l4</italic>) with differential methylation at the promoter region, in PND90 dorsal prostate tissue of rats neonatally exposed to EDCs. The methylation pattern of these 7 genes was inversely correlated to gene expression. Cell-based studies using 5-aza-cytidine-treated normal (NbE-1) and cancerous (AIT) prostate epithelial cell lines further confirmed that gene expression was regulated by DNA methylation, in 6 of the 7 genes. To provide clinical relevance, 4 of the 7 genes (<italic>PITX3, WNT10B, PAQR4</italic>, and <italic>TPD52</italic>) have been reported to be differentially methylated between PCa and normal adjacent tissues. Moreover, expression of the 7 genes is associated with the recurrence-free survival of PCa patients. Taken together, we conclude that DNA methylation changes in our novel 7-gene signature may be an epigenetic signature associated with increased cancer susceptibility in the adult gland due to early-life exposure.</p></sec><sec sec-type="materials|methods" id="s0004"><title>Materials and methods</title><sec id="s0004-0001"><title>Animal housing and treatments</title><p>All animal treatments in this study were in accordance with the accepted standards of humane animal care and approved by the Animal Use Committee at the University of Illinois. Pregnant Sprague-Dawley (SD) rats used on postnatal day (PND) 90 were from Zivic-Miller Laboratories (Pittsburgh, PA) and shipped on gestational day 12. Animal husbandry and conditions were controlled to avoid inadvertent BPA and phytoestrogen exposures, as reported previously.<xref rid="cit0021" ref-type="bibr"><sup>21,63</sup></xref></p><p>A schematic diagram of the experimental and analytical procedures is outlined in <xref ref-type="fig" rid="f0001">Figure&#x000a0;1</xref>. Pregnant dams were monitored and the day of birth was designated as PND0. Anogenital distance was used to segregate male and female pups. Male pups were randomly assigned to one of 3 treatment groups, n = 30/group: (a) controls given tocopherol-stripped corn oil vehicle alone (Ctrl), (b) 25 &#x000b5;g EB/pup or 2,500&#x000a0;&#x000b5;g EB/kg BW (Sigma-Aldrich Chemical Co., E8515), or (c) 0.1 &#x000b5;g BPA/pup or 10&#x000a0;&#x000b5;g BPA/kg BW (Sigma-Aldrich Chemical Co., 239658). To avoid litter effects, pups from each litter were equally divided among treatment groups and toe clipped for permanent identification. Pups were subcutaneously injected in the nape of the neck with the respective steroids on PND1, 3 and 5, weaned on PND21, and siblings were housed until PND90. The dose and route of EB and BPA was based on our published study<xref rid="cit0025" ref-type="bibr"><sup>25,64</sup></xref> and utilized to maintain continuity of results.<xref rid="cit0027" ref-type="bibr"><sup>27</sup></xref> We had previously characterized the BPA pharmacokinetics in PND3 neonates following a single subcutaneous injection of 10&#x000a0;&#x000b5;g/kg BW of the endocrine disruptor.<xref rid="cit0034" ref-type="bibr"><sup>34</sup></xref> The mean sera unconjugated BPA level reached a Cmax of 1.77&#x000a0;ng/ml in 0.5 h but rapidly declined to 0.7&#x000a0;ng/ml and 0.54&#x000a0;ng/ml at 1 h and 2 h, respectively, post-injection. These findings suggest a rather rapid rate of bio-degradation of BPA in PND3 neonates, making it unlikely that BPA will reach higher levels upon multiple injections (PND1, 3, 5). However, since we did not have actual measurements of circulating BPA in the neonates during this period, this conclusion may simply be a conjecture. Yet, it should be noted that these levels and those reported before in rodent neonates<xref rid="cit0034" ref-type="bibr"><sup>34,65</sup></xref> are well within the range reported for human developmental exposures.<xref rid="cit0012" ref-type="bibr"><sup>12,15,34</sup></xref></p></sec><sec id="s0004-0002"><title>Genomic DNA extraction from dorsal prostate</title><p>Genomic DNA was extracted from the rat dorsal prostate using DNeasy Blood &#x00026; Tissue kit (Qiagen, Valencia, CA) and in the presence of RNase A (Qiagen 19101) according to the manufacturer's protocol. All reagents were supplied in the kit. In brief, the tissue was lyzed in Buffer ATL with proteinase K at 56&#x000b0;C until the tissue was completely lyzed. The lysate was incubated with 100&#x000a0;mg/ml RNase A and mixed thoroughly with equal portions of Buffer AL and 100% ethanol. The mixture was loaded on to a DNeasy Mini spin column, and washed with Buffer AW1 and Buffer AW2 consecutively by centrifugation. Genomic DNA was eluted with DEPC water diluted Buffer AE.</p></sec><sec id="s0004-0003"><title>Methylated CpG island Recovery Assay (MIRA)-assisted Methylation array analysis</title><p>A total of 5, 4, and 5 PND90 prostate genomic DNA samples from EB, BPA, and Ctrl group, respectively, were used to perform the MIRA-assisted genome-wide methylation analysis. In brief, 4.5&#x000a0;&#x000b5;g genomic DNA was sonicated by Bioruptor (Diagenode, Belgium) to obtain 300&#x02013;500&#x000a0;bp fragments. The methylated DNA fraction was enriched using MethylCollector Ultra kit (ActiveMotif, 55005) via MIRA-assisted methylated DNA enrichment with proper enrichment controls. It should be noted that the MIRA-, also known as MBD2-, assisted procedure enriches CpG-dense sequences that are likely in CpG islands.<xref rid="cit0066" ref-type="bibr"><sup>66</sup></xref> The methylation-enriched DNA and its corresponding Input were then amplified using GenomePlex WGA kit (Sigma-Aldrich, WGA2), labeled with Cy3/Cy5 dyes, and co-hybridized in Rat ChIP 385K Promoter 2 array set (Roche NimbleGen, Madison, WI) according to the manufacturer's protocol. The arrays have &#x0223c;780,000 probes with probe sizes ranging from 50&#x02013;70&#x000a0;mers in length and median probe spacing of 105&#x000a0;bp, covering &#x0223c;16,000 regions primarily in promoter regions of &#x0223c;23,000 transcripts from known genes. These regions principally contain CpG-dense DNA sequences. The probes are typically placed at 4,500&#x000a0;bp upstream and 1,125&#x000a0;bp downstream from the transcriptional start site (TSS). The estimated coverage approximates 97Mb and 3.7% coverage of the rat genome.<xref rid="cit0067" ref-type="bibr"><sup>67</sup></xref> Thus, the design of the experiments was to focus on CpG rich regions within or near known or predicted gene promoters. This design has the advantage of increasing the hit rate and reducing noise, but does have the deficit of biasing toward gene promoters and having low coverage of the overall rat genome and DMRs not assisted with gene promoters.</p></sec><sec id="s0004-0004"><title>Methylation array data analysis</title><p>Data analysis was performed using R and Bioconductor packages.<xref rid="cit0068" ref-type="bibr"><sup>68</sup></xref> The log-ratios of Cy5 to Cy3 (M values) were first normalized using GC-loess normalization. The average M value was then calculated for each probe across all samples in the same group. The significantly enriched regions were identified using sliding window analysis for each group separately. In this analysis, a window of 750 bps around each probe was considered at a time and RandomSet statistic<xref rid="cit0069" ref-type="bibr"><sup>69</sup></xref> was calculated on the average M values of all probes in the window to estimate the enrichment of the probes in the window when compared to the background. Since there is no enrichment of immunoprecipitated DNA among the probes in the window, the RandomSet statistic, which is defined as the average of the average M values in the window, is approximately distributed as the normal random variable. The <italic>P</italic>-value of each window was obtained based on the RandomSet statistic and adjusted by the false discovery rate. Windows that were significantly enriched (<italic>P</italic> &#x0003c; 10<sup>&#x02212;5</sup>) in any of the groups (EB, BPA, and Ctrl) were mapped to genes and were further filtered, where differentially methylated genes were selected based on the difference of mBar values of treatment group (EB/BPA) when compared to Ctrl and at different cutoff levels of <italic>P</italic>-value (<xref ref-type="fig" rid="f0001">Fig.&#x000a0;1</xref>). Using this approach, a methylation bar plot was generated for each promoter region in the 3 groups (<xref ref-type="fig" rid="f0002">Fig.&#x000a0;2</xref>). In a given promoter region, the difference in height of the bars (mBar) between treated and Ctrl groups represents the difference in probe intensity, i.e., the difference in promoter methylation status. When compared with the control, a positive and negative mBar difference in the treated group indicates promoter hyper- and hypo-methylation, respectively. Primers were then designed based on these differentially methylated regions for validation using bisulfite sequencing analysis.</p></sec><sec id="s0004-0005"><title>Bisulfite PCR sequencing analysis</title><p>Based on the methylation array bar plot, significant differential methylated regions flanking the gene transcription start sites were selected for methylation validation using bisulfite sequencing. Primers used for bisulfite sequencing were designed with MethPrimer.<xref rid="cit0037" ref-type="bibr"><sup>37</sup></xref> (Supplemental Table&#x000a0;S6) Genomic DNA was bisulfite modified using an EZ DNA Methylation kit (Zymo Research, D5001). In brief, 500&#x000a0;ng genomic DNA diluted with M-Dilution buffer was incubated at 37&#x000b0;C for 15&#x000a0;min, mixed with CT reagent and incubated for 16&#x000a0;hours at 50&#x000b0;C. The reaction was then mixed with Binding buffer, loaded to a spin column, washed, incubated with desulphonation buffer at room temperature for 20&#x000a0;min, and eluted with 40&#x000a0;&#x000b5;l elution buffer. Bisulfite PCR was performed using 2&#x000a0;&#x000b5;l bisulfite modified DNA and Platinum Taq DNA Polymerase (Invitrogen, 10966026) in a 25&#x000a0;&#x000b5;l reaction according to the manufacturer's protocol. Following 40 cycles of PCR amplification with the annealing temperature at 55&#x000b0;C, the amplicons were gel-purified and TA-cloned into pGEMT-easy vector (Promega, A1360). Plasmids from a single <italic>E. coli</italic> colony were amplified using TempliPhi DNA amplification kits (GE Healthcare, 25640010) and sequenced (Macrogen USA, Rockville, MD). The methylation status of each CpG site was analyzed using BiQ Analyzer.<xref rid="cit0070" ref-type="bibr"><sup>70</sup></xref></p><p>To validate the promoter methylation status of genes identified from the PND90 prostate microarray analysis, the same amount of DNA from each animal of the same treatment group was mixed for bisulfite sequencing with &#x0223c;12 clones per group. To further compare methylation pattern of promoter DMR of the 7 selected gene candidates, bisulfite sequencing analysis on 6 samples each from individual animal was performed with &#x0223c;8&#x02013;12 clones selected per sample.</p></sec><sec id="s0004-0006"><title>Treatment of NbE-1 and AIT cells</title><p>Rat prostatic epithelial cell lines, the immortalized normal prostatic epithelial cell line NbE-1<xref rid="cit0038" ref-type="bibr"><sup>38</sup></xref> and the tumorigenic cell line AIT<xref rid="cit0039" ref-type="bibr"><sup>39</sup></xref> were maintained in DMEM/F12 medium (Invitrogen, 11330057) supplemented with 5% fetal bovine serum (HyClone, 35-010-CV), 1X insulin-transferrin-selenium (Invitrogen, 41400045), 1&#x000a0;mM sodium pyruvate (Invitrogen, 11360070), and 100&#x000a0;mM minimum nonessential amino acids (Invitrogen, 11140076). The cells were seeded and treated with 0.5&#x000a0;&#x000b5;M or 1.0&#x000a0;&#x000b5;M 5-aza-2-deoxycytidine (5-aza-dC; Tocris, 2624), a DNA methylation inhibitor, every 2 d for 8 d as previously described.<xref rid="cit0025" ref-type="bibr"><sup>25,32</sup></xref> Treatment with 0.1% dimethylsulfoxide (DMSO; Sigma D4540) was used as control (Ctrl) in each experimental set. Cell lysates were stored in TRIzol reagent for RNA extraction.</p></sec><sec id="s0004-0007"><title>RNA extraction and real-time RT-qPCR</title><p>Dorsal prostate tissue was homogenized in TRIzol reagent (Invitrogen, 15596) using Precellys 24 homogenizer (Bertin Technologies, France) and extracted according to the manufacturer's protocol. One microgram total RNA was reversed transcribed using SuperScript III Reverse Transcriptase (Invitrogen, 18080085) in a 20&#x000a0;&#x000b5;l reaction. Primers for real-time RT-qPCR were designed using Primer-BLAST program (Supplemental Table&#x000a0;S7). qPCR analysis was performed in a 7500 Fast Real-Time System (ABI, Foster City, CA) in triplicate in a 20&#x000a0;&#x000b5;l reaction. Target gene expression was normalized against the individual endogenous <italic>Rpl19</italic><xref rid="cit0034" ref-type="bibr"><sup>34</sup></xref> and relative gene expression was calculated using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method.<xref rid="cit0030" ref-type="bibr"><sup>30</sup></xref> Similarly, total RNA from treated cells was extracted using TRIzol reagent (Invitrogen, 15596-018) according to the manufacturer's protocol and reversed transcribed for qPCR analyses as previously described.<xref rid="cit0030" ref-type="bibr"><sup>30</sup></xref></p></sec><sec id="s0004-0008"><title>Functional connectivity analysis</title><p>Ingenuity Pathway Analysis (IPA; Qiagen, Redwood City) was performed as previously described<xref rid="cit0009" ref-type="bibr"><sup>9</sup></xref> for analyzing, integrating, and interpreting the data generated from the methylation array.</p></sec><sec id="s0004-0009"><title>Association with the recurrence-free survival of PCa patients</title><p>RNAseq data (RNAseqV2, level 3) from 497 PCa subjects as well as their associated clinical data (Biotab) were downloaded from the TCGA database on Feb 1<sup>st</sup> 2016. Expression levels of the 7 genes were pulled from normalized RNAseq gene results. The data were variance stabilizing transformed before dichotomizing into 2 groups by K-means clustering analysis. Recurrence-free survival was determined based on &#x0201c;days to new tumor event after initial treatment.&#x0201d; Survival analysis with log rank test as well as hazard ratio were calculated using GraphPad Prism software (La Jolla, CA).</p></sec><sec id="s0004-0010"><title>Statistical analysis</title><p>Data are expressed as mean &#x000b1; SEM. There were at least 3 individual experimental sets for gene expression analysis. Bisulfite sequencing (BS) analysis of the 7 selected gene candidates was performed on 6 individual samples, with &#x0223c;8&#x02013;12 clones per group. One-way ANOVA and Tukey test were used for comparison among groups. <italic>P</italic> &#x0003c; 0.05 was considered as statistically significant.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SM2154"><caption><title>KEPI_A_1208891_s02.zip</title></caption><media xlink:href="kepi-11-09-1208891-s001.zip" mimetype="application" mime-subtype="zip" orientation="portrait" id="d37e289" position="anchor"/></supplementary-material></sec></body><back><sec><title>Disclosure of potential conflicts of interest</title><p>No potential conflicts of interest were disclosed.</p></sec><sec><title>Acknowledgments</title><p>The results published here are in whole or in part based upon data generated by the TCGA Research Network: <ext-link ext-link-type="uri" xlink:href="http://cancergenome.nih.gov/">http://cancergenome.nih.gov/</ext-link>. We thank The Genomics, Epigenomics, and Sequencing Core for the array service. We also thank Lynn Birch, Wen Yang Hu, Saikumar Karyala, Miral Patel, Hong Xiao and for their technical assistance and Jennifer Veevers for her excellent editing of the manuscript.</p></sec><sec><title>Funding</title><p>This study was supported in part by grants from the National Institutes of Environmental Health Sciences: R01CA015776 (SMH), R01ES015584 (GSP, SMH), RC2ES018758 (GSP, SMH, MM), RC2ES018789 (SMH, MM), U01ES019480 (SMH, MM), U01ES020988 (SMH, MM), CA172220 (GSP), and P30ES006096 (SMH, MM), the United States Department of Veterans Affairs I01BX000675 (SMH), and the Department of Defense Prostate Cancer Research Program W81XWH-06-1-0373 (WT) and W81XWH-15-1-0496 (AC).</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubin</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Bisphenol</surname><given-names>A</given-names></name></person-group>
<article-title>an endocrine disruptor with widespread exposure and multiple effects</article-title>. <source>J Steroid Biochem Mol Biol</source>
<year>2011</year>; <volume>127</volume>:<fpage>27</fpage>-<lpage>34</lpage>; PMID:21605673; http://dx.doi.org/26493093<pub-id pub-id-type="doi">10.1016/j.jsbmb.2011.05.002</pub-id><pub-id pub-id-type="pmid">21605673</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seachrist</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Bonk</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Soto</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Keri</surname><given-names>RA</given-names></name></person-group>. <article-title>A review of the carcinogenic potential of bisphenol A</article-title>. <source>Reprod Toxicol</source>
<year>2015</year>; 59:167-82; PMID:26493093; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.reprotox.2015.09.006</pub-id><?supplied-pmid 26493093?><pub-id pub-id-type="pmid">26493093</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandenberg</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Maffini</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Sonnenschein</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Soto</surname><given-names>AM</given-names></name></person-group>
<article-title>Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption</article-title>. <source>EndocrRev</source>
<year>2009</year>; <volume>30</volume>:<fpage>75</fpage>-<lpage>95</lpage>; PMID:19074586; http://dx.doi.org/18171687<pub-id pub-id-type="doi">10.1210/er.2008-0021</pub-id>
</mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavallaro</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mariani</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lancini</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Latorre</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Caccia</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gullo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Valotta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>DeBiasi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Spinardi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ronchi</surname><given-names>A</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants</article-title>. <source>Development</source>
<year>2008</year>; <volume>135</volume>:<fpage>541</fpage>-<lpage>57</lpage>; PMID:18171687; http://dx.doi.org/<pub-id pub-id-type="doi">10.1242/dev.010801</pub-id><?supplied-pmid 18171687?><pub-id pub-id-type="pmid">18171687</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fallen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Abaan</surname><given-names>HO</given-names></name>, <name name-style="western"><surname>Hayran</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wodajo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>MacDonald</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Toretsky</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Uren</surname><given-names>A</given-names></name></person-group>. <article-title>Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival</article-title>. <source>Pediatric blood &#x00026; cancer</source>
<year>2008</year>; <volume>51</volume>:<fpage>349</fpage>-<lpage>55</lpage>; PMID:18465804; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/pbc.21595</pub-id><?supplied-pmid 18465804?><pub-id pub-id-type="pmid">18465804</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Modugno</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Weissfeld</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Trump</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Zmuda</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Shea</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cauley</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Ferrell</surname><given-names>RE</given-names></name></person-group>. <article-title>Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk</article-title>. <source>Clin Cancer Res</source>
<year>2001</year>; <volume>7</volume>:<fpage>3092</fpage>-<lpage>6</lpage>; PMID:11595700<?supplied-pmid 11595700?><pub-id pub-id-type="pmid">11595700</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otsubo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Akiyama</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yanagihara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yuasa</surname><given-names>Y</given-names></name></person-group>. <article-title>SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis</article-title>. <source>Br J Cancer</source>
<year>2008</year>; <volume>98</volume>:<fpage>824</fpage>-<lpage>31</lpage>; PMID:18268498; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/sj.bjc.6604193</pub-id><?supplied-pmid 18268498?><pub-id pub-id-type="pmid">18268498</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calafat</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Kuklenyik</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Reidy</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Caudill</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Ekong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Needham</surname><given-names>LL</given-names></name></person-group>. <article-title>Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population</article-title>. <source>Environ Health Perspect</source>
<year>2005</year>; <volume>113</volume>:<fpage>391</fpage>-<lpage>5</lpage>; PMID:15811827; http://dx.doi.org/<pub-id pub-id-type="doi">10.1289/ehp.7534</pub-id><?supplied-pmid 15811827?><pub-id pub-id-type="pmid">15811827</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Medvedovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tam</surname><given-names>NN</given-names></name></person-group>. <article-title>Bisphenol A Disrupts HNF4alpha-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats</article-title>. <source>Endocrinology</source>
<year>2016</year>; <volume>157</volume>:<fpage>207</fpage>-<lpage>19</lpage>; PMID:26496021; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/en.2015-1363</pub-id><?supplied-pmid 26496021?><pub-id pub-id-type="pmid">26496021</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarapore</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ying</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ouyang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Burke</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bracken</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name></person-group>. <article-title>Exposure to bisphenol A correlates with early-onset prostate cancer and promotes centrosome amplification and anchorage-independent growth in vitro</article-title>. <source>PloS one</source>
<year>2014</year>; <volume>9</volume>:<fpage>e90332</fpage>; PMID:24594937; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0090332</pub-id><?supplied-pmid 24594937?><pub-id pub-id-type="pmid">24594937</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balakrishnan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Henare</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thorstensen</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Ponnampalam</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>MD</given-names></name></person-group>
<article-title>Transfer of bisphenol A across the human placenta</article-title>. <source>AmJObstetGynecol</source>
<year>2010</year>; <volume>202</volume>:<fpage>393</fpage>-<lpage>7</lpage>; PMID:20350650; http://dx.doi.org/23941471<pub-id pub-id-type="doi">10.1016/j.ajog.2010.01.025</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerona</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Woodruff</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Dickenson</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Friesen</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Fujimoto</surname><given-names>VY</given-names></name>, <name name-style="western"><surname>Hunt</surname><given-names>PA</given-names></name></person-group>. <article-title>Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population</article-title>. <source>Environ Sci Technol</source>
<year>2013</year>; <volume>47</volume>:<fpage>12477</fpage>-<lpage>85</lpage>; PMID:23941471; http://dx.doi.org/<pub-id pub-id-type="doi">10.1021/es402764d</pub-id><?supplied-pmid 23941471?><pub-id pub-id-type="pmid">23941471</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Ryu</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Nam</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>DD</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Maternal and fetal exposure to bisphenol A in Korea</article-title>. <source>ReprodToxicol</source>
<year>2008</year>; <volume>25</volume>:<fpage>413</fpage>-<lpage>9</lpage>; PMID:18577445; http://dx.doi.org/19440506<pub-id pub-id-type="doi">10.1016/j.reprotox.2008.05.058</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Padmanabhan</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Siefert</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ransom</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Pinkerton</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kannan</surname><given-names>K</given-names></name></person-group>
<article-title>Maternal bisphenol-A levels at delivery: a looming problem?</article-title>
<source>JPerinatol</source>
<year>2008</year>; <volume>28</volume>:<fpage>258</fpage>-<lpage>63</lpage>; PMID:18273031; http://dx.doi.org/19440506<pub-id pub-id-type="doi">10.1038/sj.jp.7211913</pub-id><pub-id pub-id-type="pmid">18273031</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edginton</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Ritter</surname><given-names>L</given-names></name></person-group>. <article-title>Predicting plasma concentrations of bisphenol A in children younger than 2&#x000a0;years of age after typical feeding schedules, using a physiologically based toxicokinetic model</article-title>. <source>Environ Health Perspect</source>
<year>2009</year>; <volume>117</volume>:<fpage>645</fpage>-<lpage>52</lpage>; PMID:19440506; http://dx.doi.org/<pub-id pub-id-type="doi">10.1289/ehp.0800073</pub-id><?supplied-pmid 19440506?><pub-id pub-id-type="pmid">19440506</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wetherill</surname><given-names>YB</given-names></name>, <name name-style="western"><surname>Akingbemi</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Kanno</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McLachlan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Nadal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sonnenschein</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Belcher</surname><given-names>SM</given-names></name></person-group>. <article-title>In vitro molecular mechanisms of bisphenol A action</article-title>. <source>Reprod Toxicol</source>
<year>2007</year>; <volume>24</volume>:<fpage>178</fpage>-<lpage>98</lpage>; PMID:17628395; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.reprotox.2007.05.010</pub-id><?supplied-pmid 17628395?><pub-id pub-id-type="pmid">17628395</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Madueke</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Kajdacsy-Balla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name></person-group>. <article-title>Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells</article-title>. <source>Endocrinology</source>
<year>2011</year>; <volume>152</volume>:<fpage>2150</fpage>-<lpage>63</lpage>; PMID:21427218; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/en.2010-1377</pub-id><?supplied-pmid 21427218?><pub-id pub-id-type="pmid">21427218</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Leav</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name></person-group>. <article-title>Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats</article-title>. <source>Endocrinology</source>
<year>1998</year>; <volume>139</volume>:<fpage>424</fpage>-<lpage>7</lpage>; PMID:9421443; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/endo.139.1.5809#sthash.rMzyrNHt.dpuf</pub-id><?supplied-pmid 9421443?><pub-id pub-id-type="pmid">9421443</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Majumdar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nelles</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>CL</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium</article-title>. <source>Endocrinology</source>
<year>2014</year>; <volume>155</volume>:<fpage>805</fpage>-<lpage>17</lpage>; PMID:24424067; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/en.2013-1955</pub-id><?supplied-pmid 24424067?><pub-id pub-id-type="pmid">24424067</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acconcia</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pallottini</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Marino</surname><given-names>M</given-names></name></person-group>. <article-title>Molecular Mechanisms of Action of BPA</article-title>. <source>Dose-response</source>
<year>2015</year>; <volume>13</volume>:<fpage>1559325815610582</fpage>; PMID:26740804; http://dx.doi.org/<pub-id pub-id-type="doi">10.1177/1559325815610582</pub-id><?supplied-pmid 26740804?><pub-id pub-id-type="pmid">26740804</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriyama</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tagami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Akamizu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Usui</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Saijo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kanamoto</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hataya</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shimatsu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kuzuya</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nakao</surname><given-names>K</given-names></name></person-group>
<article-title>Thyroid hormone action is disrupted by bisphenol A as an antagonist</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2002</year>; <volume>87</volume>:<fpage>5185</fpage>-<lpage>90</lpage>; PMID:12414890; http://dx.doi.org/9655587<pub-id pub-id-type="doi">10.1210/jc.2002-020209</pub-id><pub-id pub-id-type="pmid">12414890</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lammoglia</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Short</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Bellows</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Bellows</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>MacNeil</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Hafs</surname><given-names>HD</given-names></name></person-group>. <article-title>Induced and synchronized estrus in cattle: dose titration of estradiol benzoate in peripubertal heifers and postpartum cows after treatment with an intravaginal progesterone-releasing insert and prostaglandin F2alpha</article-title>. <source>J Anim Sci</source>
<year>1998</year>; <volume>76</volume>:<fpage>1662</fpage>-<lpage>70</lpage>; PMID:9655587; http://dx.doi.org/<pub-id pub-id-type="doi">10.2527/1998.7661662x</pub-id><?supplied-pmid 9655587?><pub-id pub-id-type="pmid">9655587</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matthews</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Celius</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Halgren</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zacharewski</surname><given-names>T</given-names></name></person-group>. <article-title>Differential estrogen receptor binding of estrogenic substances: a species comparison</article-title>. <source>J Steroid Biochem Mol Biol</source>
<year>2000</year>; <volume>74</volume>:<fpage>223</fpage>-<lpage>34</lpage>; PMID:11162928; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/S0960-0760(00)00126-6</pub-id><?supplied-pmid 11162928?><pub-id pub-id-type="pmid">11162928</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toyama</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yuasa</surname><given-names>S</given-names></name></person-group>. <article-title>Effects of neonatal administration of 17beta-estradiol, beta-estradiol 3-benzoate, or bisphenol A on mouse and rat spermatogenesis</article-title>. <source>Reprod Toxicol</source>
<year>2004</year>; <volume>19</volume>:<fpage>181</fpage>-<lpage>8</lpage>; PMID:15501383; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.reprotox.2004.08.003</pub-id><?supplied-pmid 15501383?><pub-id pub-id-type="pmid">15501383</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Belmonte</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name></person-group>. <article-title>Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4</article-title>. <source>Cancer Res</source>
<year>2006</year>; <volume>66</volume>:<fpage>5624</fpage>-<lpage>32</lpage>; PMID:16740699; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-0516</pub-id><?supplied-pmid 16740699?><pub-id pub-id-type="pmid">16740699</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Habermann</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Tebeau</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Putz</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bieberich</surname><given-names>C</given-names></name></person-group>. <article-title>Influence of neonatal estrogens on rat prostate development</article-title>. <source>Reprod Fertil Dev</source>
<year>2001</year>; <volume>13</volume>:<fpage>241</fpage>-<lpage>52</lpage>; PMID:11800163; http://dx.doi.org/<pub-id pub-id-type="doi">10.1071/RD00107</pub-id><?supplied-pmid 11800163?><pub-id pub-id-type="pmid">11800163</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name></person-group>. <article-title>Early-life estrogens and prostate cancer in an animal model</article-title>. <source>J Dev Orig Health Dis</source>
<year>2010</year>; <volume>1</volume>:<fpage>365</fpage>-<lpage>70</lpage>; PMID:24795802; http://dx.doi.org/<pub-id pub-id-type="doi">10.1017/S2040174410000577</pub-id><?supplied-pmid 24795802?><pub-id pub-id-type="pmid">24795802</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernal</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Jirtle</surname><given-names>RL</given-names></name></person-group>. <article-title>Epigenomic disruption: the effects of early developmental exposures</article-title>. <source>Birth Defects Res A Clin Mol Teratol</source>
<year>2010</year>; <volume>88</volume>:<fpage>938</fpage>-<lpage>44</lpage>; PMID:20568270; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/bdra.20685</pub-id><?supplied-pmid 20568270?><pub-id pub-id-type="pmid">20568270</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ansari</surname><given-names>KI</given-names></name>, <name name-style="western"><surname>Bobzean</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Perrotti</surname><given-names>LI</given-names></name>, <name name-style="western"><surname>Mandal</surname><given-names>SS</given-names></name></person-group>. <article-title>Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo</article-title>. <source>J Steroid Biochem Mol Biol</source>
<year>2014</year>; <volume>141</volume>:<fpage>160</fpage>-<lpage>70</lpage>; PMID:24533973; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.jsbmb.2014.02.002</pub-id><?supplied-pmid 24533973?><pub-id pub-id-type="pmid">24533973</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Cheong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Medvedovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>YK</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification</article-title>. <source>Endocrinology</source>
<year>2015</year>; <volume>156</volume>:<fpage>3984</fpage>-<lpage>95</lpage>; PMID:26248216; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/en.2015-1067</pub-id><?supplied-pmid 26248216?><pub-id pub-id-type="pmid">26248216</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nahar</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kannan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dolinoy</surname><given-names>DC</given-names></name></person-group>. <article-title>In utero bisphenol A concentration, metabolism, and global DNA methylation across matched placenta, kidney, and liver in the human fetus</article-title>. <source>Chemosphere</source>
<year>2015</year>; <volume>124</volume>:<fpage>54</fpage>-<lpage>60</lpage>; PMID:25434263; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.chemosphere.2014.10.071</pub-id><?supplied-pmid 25434263?><pub-id pub-id-type="pmid">25434263</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Morey</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name></person-group>. <article-title>Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life</article-title>. <source>Endocrinology</source>
<year>2012</year>; <volume>153</volume>:<fpage>42</fpage>-<lpage>55</lpage>; PMID:22109888; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/en.2011-1308</pub-id><?supplied-pmid 22109888?><pub-id pub-id-type="pmid">22109888</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Trevino</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Bosland</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Medvedovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Kannan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>CL</given-names></name></person-group>. <article-title>Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate</article-title>. <source>Epigenetics</source>
<year>2015</year>; <volume>10</volume>:<fpage>127</fpage>-<lpage>34</lpage>; PMID:25612011; http://dx.doi.org/<pub-id pub-id-type="doi">10.1080/15592294.2015.1009768</pub-id><?supplied-pmid 25612011?><pub-id pub-id-type="pmid">25612011</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Kannan</surname><given-names>K</given-names></name></person-group>. <article-title>Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats</article-title>. <source>Reprod Toxicol</source>
<year>2011</year>; <volume>31</volume>:<fpage>1</fpage>-<lpage>9</lpage>; PMID:20887781; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.reprotox.2010.09.009</pub-id><?supplied-pmid 20887781?><pub-id pub-id-type="pmid">20887781</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vermeulen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kaufman</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Goemaere</surname><given-names>S</given-names></name>, <name name-style="western"><surname>van Pottelberg</surname><given-names>I</given-names></name></person-group>. <article-title>Estradiol in elderly men</article-title>. <source>Aging Male</source>
<year>2002</year>; <volume>5</volume>:<fpage>98</fpage>-<lpage>102</lpage>; PMID:12198740; http://dx.doi.org/<pub-id pub-id-type="doi">10.1080/tam.5.2.98.102</pub-id><?supplied-pmid 12198740?><pub-id pub-id-type="pmid">12198740</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name></person-group>
<article-title>Developmental reprogramming of cancer susceptibility</article-title>. <source>Nat Rev Cancer</source>
<year>2012</year>; <volume>12</volume>:<fpage>479</fpage>-<lpage>86</lpage>; PMID:22695395; http://dx.doi.org/17951806<pub-id pub-id-type="doi">10.1038/nrc3220</pub-id>
<pub-id pub-id-type="pmid">22695395</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>LC</given-names></name></person-group>. <article-title>Designing PCR primer for DNA methylation mapping</article-title>. <source>Methods Mol Biol</source>
<year>2007</year>; <volume>402</volume>:<fpage>371</fpage>-<lpage>84</lpage>; PMID:17951806; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/978-1-59745-528-2</pub-id><?supplied-pmid 17951806?><pub-id pub-id-type="pmid">17951806</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>LW</given-names></name></person-group>. <article-title>Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen</article-title>. <source>Endocrinology</source>
<year>1989</year>; <volume>125</volume>:<fpage>2719</fpage>-<lpage>27</lpage>; PMID:2792005; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/endo-125-5-2719</pub-id><?supplied-pmid 2792005?><pub-id pub-id-type="pmid">2792005</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Leav</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Damassa</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Merk</surname><given-names>FB</given-names></name>, <name name-style="western"><surname>Seto</surname><given-names>HS</given-names></name></person-group>. <article-title>Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats</article-title>. <source>Cancer Res</source>
<year>1988</year>; <volume>48</volume>:<fpage>609</fpage>-<lpage>14</lpage>; PMID:3257169<?supplied-pmid 3257169?><pub-id pub-id-type="pmid">3257169</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albertsen</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Hanley</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Fine</surname><given-names>J</given-names></name></person-group>. <article-title>20-year outcomes following conservative management of clinically localized prostate cancer</article-title>. <source>Jama</source>
<year>2005</year>; <volume>293</volume>:<fpage>2095</fpage>-<lpage>101</lpage>; PMID:15870412; http://dx.doi.org/<pub-id pub-id-type="doi">10.1001/jama.293.17.2095</pub-id><?supplied-pmid 15870412?><pub-id pub-id-type="pmid">15870412</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Birch</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pu</surname><given-names>Y</given-names></name></person-group>. <article-title>The role of estrogens in normal and abnormal development of the prostate gland</article-title>. <source>Ann N Y Acad Sci</source>
<year>2006</year>; <volume>1089</volume>:<fpage>1</fpage>-<lpage>13</lpage>; PMID:17261752; http://dx.doi.org/<pub-id pub-id-type="doi">10.1196/annals.1386.009</pub-id><?supplied-pmid 17261752?><pub-id pub-id-type="pmid">17261752</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Bedolla</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Mikhailova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Prihoda</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Troyer</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Kreisberg</surname><given-names>JI</given-names></name></person-group>. <article-title>Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation</article-title>. <source>Endocrine-related Cancer</source>
<year>2005</year>; <volume>12</volume>:<fpage>119</fpage>-<lpage>34</lpage>; PMID:15788644; http://dx.doi.org/<pub-id pub-id-type="doi">10.1677/erc.1.00835</pub-id><?supplied-pmid 15788644?><pub-id pub-id-type="pmid">15788644</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Grobholz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Abel</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Trojan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Angel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mayer</surname><given-names>D</given-names></name></person-group>. <article-title>Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer</article-title>. <source>Int J Cancer</source>
<year>2003</year>; <volume>107</volume>:<fpage>676</fpage>-<lpage>80</lpage>; PMID:14520710; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/ijc.11471</pub-id><?supplied-pmid 14520710?><pub-id pub-id-type="pmid">14520710</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal">Sanjeev S, MacLennan GT, Hartman DJ, Fu P, Resnick MI, and Gupta S. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. International Journal of Cancer 2007; 121(7):1424-1432; PMID:17551921; http://dx.doi.org/11404460<pub-id pub-id-type="doi">10.1002/ijc.22862</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>C</given-names></name></person-group>. <article-title>Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2001</year>; <volume>98</volume>:<fpage>7200</fpage>-<lpage>5</lpage>; PMID:11404460; http://dx.doi.org/<pub-id pub-id-type="doi">10.1073/pnas.121173298</pub-id><?supplied-pmid 11404460?><pub-id pub-id-type="pmid">11404460</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Della Rocca</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ballo</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Schwinn</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Luttrell</surname><given-names>LM</given-names></name></person-group>. <article-title>Activation of extracellular signal-regulated kinase in human prostate cancer</article-title>. <source>J Urol</source>
<year>1999</year>; <volume>162</volume>:<fpage>1537</fpage>-<lpage>42</lpage>; PMID:10492251; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/S0022-5347(05)68354-1</pub-id><?supplied-pmid 10492251?><pub-id pub-id-type="pmid">10492251</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ouyang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Banach-Petrosky</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Gerald</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Abate-Shen</surname><given-names>C</given-names></name></person-group>. <article-title>Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2006</year>; <volume>103</volume>:<fpage>14477</fpage>-<lpage>82</lpage>; PMID:16973750; http://dx.doi.org/<pub-id pub-id-type="doi">10.1073/pnas.0606836103</pub-id><?supplied-pmid 16973750?><pub-id pub-id-type="pmid">16973750</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mou</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lv</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>X</given-names></name>, et&#x000a0;al.</person-group>
<article-title>SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell</article-title>. <source>J Mol Cell Biol</source>
<year>2011</year>; <volume>3</volume>:<fpage>230</fpage>-<lpage>8</lpage>; PMID:21415100; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/jmcb/mjr002</pub-id><?supplied-pmid 21415100?><pub-id pub-id-type="pmid">21415100</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kregel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kiriluk</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Rosen</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Reyes</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Otto</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Tom</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Paner</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Szmulewitz</surname><given-names>RZ</given-names></name>, <name name-style="western"><surname>Vander Griend</surname><given-names>DJ</given-names></name></person-group>. <article-title>Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer</article-title>. <source>PloS one</source>
<year>2013</year>; <volume>8</volume>:<fpage>e53701</fpage>; PMID:23326489; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0053701</pub-id><?supplied-pmid 23326489?><pub-id pub-id-type="pmid">23326489</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miranda-Carboni</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Krum</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nava</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>QE</given-names></name>, <name name-style="western"><surname>Pervin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Collado-Hidalgo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Galic</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zack</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name>, et&#x000a0;al.</person-group>
<article-title>A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors</article-title>. <source>Gen Dev</source>
<year>2008</year>; <volume>22</volume>:<fpage>3121</fpage>-<lpage>34</lpage>; PMID:19056892; http://dx.doi.org/<pub-id pub-id-type="doi">10.1101/gad.1692808</pub-id><?supplied-pmid 19056892?><pub-id pub-id-type="pmid">19056892</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>N</given-names></name></person-group>. <article-title>SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/beta-catenin signal network</article-title>. <source>Cancer Lett</source>
<year>2013</year>; <volume>336</volume>:<fpage>379</fpage>-<lpage>89</lpage>; PMID:23545177; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.canlet.2013.03.027</pub-id><?supplied-pmid 23545177?><pub-id pub-id-type="pmid">23545177</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ummanni</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Teller</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Junker</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zimmermann</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Venz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scharf</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Giebel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Walther</surname><given-names>R</given-names></name></person-group>. <article-title>Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells</article-title>. <source>FEBS J</source>
<year>2008</year>; <volume>275</volume>:<fpage>5703</fpage>-<lpage>13</lpage>; PMID:18959755; http://dx.doi.org/<pub-id pub-id-type="doi">10.1111/j.1742-4658.2008.06697.x</pub-id><?supplied-pmid 18959755?><pub-id pub-id-type="pmid">18959755</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tennstedt</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bolch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Strobel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Minner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Burkhardt</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Grob</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Masser</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sauter</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schlomm</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>R</given-names></name></person-group>. <article-title>Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR</article-title>. <source>Int J Oncol</source>
<year>2014</year>; <volume>44</volume>:<fpage>609</fpage>-<lpage>15</lpage>; PMID:24317684; http://dx.doi.org/<pub-id pub-id-type="doi">10.3892/ijo.2013.2200</pub-id><?supplied-pmid 24317684?><pub-id pub-id-type="pmid">24317684</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Duin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Marion</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vissers</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>van Weerden</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Schroder</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Hop</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>van der Kwast</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>C</given-names></name>, <name name-style="western"><surname>van Dekken</surname><given-names>H</given-names></name></person-group>. <article-title>High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer</article-title>. <source>Genes Chromosomes Cancer</source>
<year>2005</year>; <volume>44</volume>:<fpage>438</fpage>-<lpage>49</lpage>; PMID:16130124; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/gcc.20259</pub-id><?supplied-pmid 16130124?><pub-id pub-id-type="pmid">16130124</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fillion</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Labrie</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Grenier</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fournier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>L</given-names></name>, <name name-style="western"><surname>El-Alfy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Labrie</surname><given-names>C</given-names></name></person-group>. <article-title>AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells</article-title>. <source>Cancer Res</source>
<year>2002</year>; <volume>62</volume>:<fpage>721</fpage>-<lpage>33</lpage>; PMID:11830526<?supplied-pmid 11830526?><pub-id pub-id-type="pmid">11830526</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Fuessel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Baretton</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Lohse</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tomasetti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Unversucht</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Froehner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wirth</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Meye</surname><given-names>A</given-names></name></person-group>. <article-title>Quantitative multi-gene expression profiling of primary prostate cancer</article-title>. <source>Prostate</source>
<year>2006</year>; <volume>66</volume>:<fpage>1521</fpage>-<lpage>34</lpage>; PMID:16921506; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/pros.20490</pub-id><?supplied-pmid 16921506?><pub-id pub-id-type="pmid">16921506</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wissmann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wild</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Kaiser</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Roepcke</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stoehr</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Woenckhaus</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kristiansen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Hofstaedter</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hartmann</surname><given-names>A</given-names></name>, et&#x000a0;al.</person-group>
<article-title>WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer</article-title>. <source>J Pathol</source>
<year>2003</year>; <volume>201</volume>:<fpage>204</fpage>-<lpage>12</lpage>; PMID:14517837; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/path.1449</pub-id><?supplied-pmid 14517837?><pub-id pub-id-type="pmid">14517837</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Calderon-Gierszal</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>WY</given-names></name></person-group>. <article-title>Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility</article-title>. <source>Endocrinology</source>
<year>2015</year>; <volume>156</volume>:<fpage>3451</fpage>-<lpage>7</lpage>; PMID:26241068; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/en.2015-1357</pub-id><?supplied-pmid 26241068?><pub-id pub-id-type="pmid">26241068</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lindberg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Egevad</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gronberg</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Isaacs</surname><given-names>WB</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Identification of new differentially methylated genes that have potential functional consequences in prostate cancer</article-title>. <source>PloS one</source>
<year>2012</year>; <volume>7</volume>:<fpage>e48455</fpage>; PMID:23119026; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0048455</pub-id><?supplied-pmid 23119026?><pub-id pub-id-type="pmid">23119026</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kato</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Araki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Itoyama</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kogure</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>K</given-names></name></person-group>. <article-title>An immunohistochemical study of heat shock protein-27 in the hippocampus in a gerbil model of cerebral ischemia and ischemic tolerance</article-title>. <source>Neuroscience</source>
<year>1995</year>; <volume>68</volume>:<fpage>65</fpage>-<lpage>71</lpage>; PMID:7477936; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/0306-4522(95)00141-5</pub-id><?supplied-pmid 7477936?><pub-id pub-id-type="pmid">7477936</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alonso-Magdalena</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ropero</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Soriano</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Garcia-Arevalo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ripoll</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fuentes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Quesada</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Nadal</surname><given-names>A</given-names></name></person-group>. <article-title>Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways</article-title>. <source>Mol Cell Endocrinol</source>
<year>2012</year>; <volume>355</volume>:<fpage>201</fpage>-<lpage>7</lpage>; PMID:22227557; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.mce.2011.12.012</pub-id><?supplied-pmid 22227557?><pub-id pub-id-type="pmid">22227557</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>QK</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>KM</given-names></name></person-group>. <article-title>Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest</article-title>. <source>Cell Death Differ</source>
<year>2010</year>; <volume>17</volume>:<fpage>1511</fpage>-<lpage>23</lpage>; PMID:20203690; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/cdd.2010.20</pub-id><?supplied-pmid 20203690?><pub-id pub-id-type="pmid">20203690</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gagne</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aylward</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Hays</surname><given-names>SM</given-names></name></person-group>
<article-title>Biomonitoring Equivalents for bisphenol A (BPA)</article-title>. <source>Regul Toxicol Pharmacol</source>
<year>2010</year>; <volume>58</volume>:<fpage>18</fpage>-<lpage>24</lpage>; PMID:20541576; http://dx.doi.org/1597166<pub-id pub-id-type="doi">10.1016/j.yrtph.2010.06.005</pub-id><pub-id pub-id-type="pmid">20541576</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name></person-group>. <article-title>Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression</article-title>. <source>Endocrinology</source>
<year>1992</year>; <volume>130</volume>:<fpage>3703</fpage>-<lpage>14</lpage>; PMID:1597166; http://dx.doi.org/<pub-id pub-id-type="doi">10.1210/en.130.6.3703</pub-id><?supplied-pmid 1597166?><pub-id pub-id-type="pmid">1597166</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Draganov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Markham</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Beyer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Waechter</surname><given-names>JM</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Dimond</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Budinsky</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Shiotsuka</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Snyder</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Ehman</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Hentges</surname><given-names>SG</given-names></name></person-group>. <article-title>Extensive metabolism and route-dependent pharmacokinetics of bisphenol A (BPA) in neonatal mice following oral or subcutaneous administration</article-title>. <source>Toxicology</source>
<year>2015</year>; <volume>333</volume>:<fpage>168</fpage>-<lpage>78</lpage>; PMID:25929835; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.tox.2015.04.012</pub-id><?supplied-pmid 25929835?><pub-id pub-id-type="pmid">25929835</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rauch</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Pfeifer</surname><given-names>GP</given-names></name></person-group>. <article-title>MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells</article-title>. <source>Cancer Res</source>
<year>2006</year>; <volume>66</volume>:<fpage>7939</fpage>-<lpage>47</lpage>; PMID:16912168; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-1888</pub-id><?supplied-pmid 16912168?><pub-id pub-id-type="pmid">16912168</pub-id></mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerrero-Bosagna</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Settles</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lucker</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Skinner</surname><given-names>MK</given-names></name></person-group>. <article-title>Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome</article-title>. <source>PloS one</source>
<year>2010</year>; <volume>5</volume>:e13100; PMID:20927350; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0013100</pub-id><?supplied-pmid 20927350?><pub-id pub-id-type="pmid">20927350</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gentleman</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Carey</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Bates</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Bolstad</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dettling</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dudoit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gautier</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gentry</surname><given-names>J</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Bioconductor: open software development for computational biology and bioinformatics</article-title>. <source>Gen Biol</source>
<year>2004</year>; <volume>5</volume>:<fpage>R80</fpage>; PMID:15461798; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r80</pub-id><?supplied-pmid 15461798?><pub-id pub-id-type="pmid">15461798</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newton</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Quintana</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>den Boon</surname><given-names>JA</given-names></name></person-group>
<article-title>Random set methods identify distinct aspects of the enrichment signal in gene-set analysis</article-title>. <source>AnnApplStat</source>
<year>2007</year>; <volume>1</volume>:<fpage>85</fpage>-<lpage>106</lpage>; http://dx.doi.org/doi:<pub-id pub-id-type="doi">10.1214/07-AOAS104</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bock</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Reither</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mikeska</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Paulsen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Walter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lengauer</surname><given-names>T</given-names></name></person-group>. <article-title>BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing</article-title>. <source>Bioinformatics</source>
<year>2005</year>; <volume>21</volume>:<fpage>4067</fpage>-<lpage>8</lpage>; PMID:16141249; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/bioinformatics/bti652</pub-id><?supplied-pmid 16141249?><pub-id pub-id-type="pmid">16141249</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Belkum</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Melles</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Nouwen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van Leeuwen</surname><given-names>WB</given-names></name>, <name name-style="western"><surname>van Wamel</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Vos</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Wertheim</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Verbrugh</surname><given-names>HA</given-names></name></person-group>. <article-title>Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus</article-title>. <source>Infect Genet Evol</source>
<year>2009</year>; <volume>9</volume>:<fpage>32</fpage>-<lpage>47</lpage>; PMID:19000784; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.meegid.2008.09.012</pub-id><?supplied-pmid 19000784?><pub-id pub-id-type="pmid">19000784</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ming</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>W</given-names></name></person-group>. <article-title>Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson's disease</article-title>. <source>Eur J Neurol</source>
<year>2012</year>; <volume>19</volume>:<fpage>870</fpage>-<lpage>5</lpage>; PMID:22309633; http://dx.doi.org/<pub-id pub-id-type="doi">10.1111/j.1468-1331.2011.03644.x</pub-id><?supplied-pmid 22309633?><pub-id pub-id-type="pmid">22309633</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>S</given-names></name></person-group>. <article-title>Signaling of glial cell line-derived neurotrophic factor and its receptor GFRalpha1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease</article-title>. <source>J Neuropathol Exp Neurol</source>
<year>2011</year>; <volume>70</volume>:<fpage>736</fpage>-<lpage>47</lpage>; PMID:21865882; http://dx.doi.org/<pub-id pub-id-type="doi">10.1097/NEN.0b013e31822830e5</pub-id><?supplied-pmid 21865882?><pub-id pub-id-type="pmid">21865882</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>F</given-names></name></person-group>. <article-title>Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/beta-catenin pathway</article-title>. <source>Oncol Rep</source>
<year>2013</year>; <volume>29</volume>:<fpage>507</fpage>-<lpage>14</lpage>; PMID:23135473; http://dx.doi.org/<pub-id pub-id-type="doi">10.3892/or.2012.2126</pub-id><?supplied-pmid 23135473?><pub-id pub-id-type="pmid">23135473</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ouji</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nakamura-Uchiyama</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Yoshikawa</surname><given-names>M</given-names></name></person-group>. <article-title>Canonical Wnts, specifically Wnt-10b, show ability to maintain dermal papilla cells</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2013</year>; <volume>438</volume>:<fpage>493</fpage>-<lpage>9</lpage>; PMID:23916705; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.bbrc.2013.07.108</pub-id><?supplied-pmid 23916705?><pub-id pub-id-type="pmid">23916705</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wend</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Runke</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wend</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Anchondo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yesayan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jardon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hardie</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Loddenkemper</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ulasov</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Lesniak</surname><given-names>MS</given-names></name>, et&#x000a0;al.</person-group>
<article-title>WNT10B/beta-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer</article-title>. <source>EMBO Mol Med</source>
<year>2013</year>; <volume>5</volume>:<fpage>264</fpage>-<lpage>79</lpage>; PMID:23307470; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/emmm.201201320</pub-id><?supplied-pmid 23307470?><pub-id pub-id-type="pmid">23307470</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thiele</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rauner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goettsch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rachner</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Benad</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fuessel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Erdmann</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hamann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Baretton</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Wirth</surname><given-names>MP</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates</article-title>. <source>J Cell Biochem</source>
<year>2011</year>; <volume>112</volume>:<fpage>1593</fpage>-<lpage>600</lpage>; PMID:21344486; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/jcb.23070</pub-id><?supplied-pmid 21344486?><pub-id pub-id-type="pmid">21344486</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calderon-Gierszal</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name></person-group>. <article-title>Directed Differentiation of Human Embryonic Stem Cells into Prostate Organoids In Vitro and its Perturbation by Low-Dose Bisphenol A Exposure</article-title>. <source>PloS one</source>
<year>2015</year>; <volume>10</volume>:<fpage>e0133238</fpage>; PMID:26222054; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0133238</pub-id><?supplied-pmid 26222054?><pub-id pub-id-type="pmid">26222054</pub-id></mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golestaneh</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Beauchamp</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fallen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kokkinaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Uren</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dym</surname><given-names>M</given-names></name></person-group>. <article-title>Wnt signaling promotes proliferation and stemness regulation of spermatogonial stem/progenitor cells</article-title>. <source>Reproduction</source>
<year>2009</year>; <volume>138</volume>:<fpage>151</fpage>-<lpage>62</lpage>; PMID:19419993; http://dx.doi.org/<pub-id pub-id-type="doi">10.1530/REP-08-0510</pub-id><?supplied-pmid 19419993?><pub-id pub-id-type="pmid">19419993</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonez</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Naselli</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Banakh</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Niwa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>LC</given-names></name></person-group>. <article-title>Pancreatic expression and mitochondrial localization of the progestin-adipoQ receptor PAQR10</article-title>. <source>Mol Med</source>
<year>2008</year>; <volume>14</volume>:<fpage>697</fpage>-<lpage>704</lpage>; PMID:18769639; http://dx.doi.org/<pub-id pub-id-type="doi">10.2119/2008-00072.Gonez</pub-id><?supplied-pmid 18769639?><pub-id pub-id-type="pmid">18769639</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boumahdi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Driessens</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lapouge</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rorive</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nassar</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Le Mercier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Delatte</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Caauwe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lenglez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nkusi</surname><given-names>E</given-names></name>, et&#x000a0;al.</person-group>
<article-title>SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma</article-title>. <source>Nature</source>
<year>2014</year>; <volume>511</volume>:<fpage>246</fpage>-<lpage>50</lpage>; PMID:24909994; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature13305</pub-id><?supplied-pmid 24909994?><pub-id pub-id-type="pmid">24909994</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Khudyakov</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pevny</surname><given-names>L</given-names></name></person-group>. <article-title>SOX2 functions to maintain neural progenitor identity</article-title>. <source>Neuron</source>
<year>2003</year>; <volume>39</volume>:<fpage>749</fpage>-<lpage>65</lpage>; PMID:12948443; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/S0896-6273(03)00497-5</pub-id><?supplied-pmid 12948443?><pub-id pub-id-type="pmid">12948443</pub-id></mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schoenhals</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kassambara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>De Vos</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hose</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Moreaux</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>B</given-names></name></person-group>. <article-title>Embryonic stem cell markers expression in cancers</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2009</year>; <volume>383</volume>:<fpage>157</fpage>-<lpage>62</lpage>; PMID:19268426; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.bbrc.2009.02.156</pub-id><?supplied-pmid 19268426?><pub-id pub-id-type="pmid">19268426</pub-id></mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez-Vega</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Garcia-Suarez</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Crespo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Astudillo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Quiros</surname><given-names>LM</given-names></name></person-group>. <article-title>Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character</article-title>. <source>BMC Cancer</source>
<year>2015</year>; <volume>15</volume>:<fpage>742</fpage>; PMID:26482785; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/s12885-015-1724-9</pub-id><?supplied-pmid 26482785?><pub-id pub-id-type="pmid">26482785</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Futtner</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rock</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Whitworth</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Hogan</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Onaitis</surname><given-names>MW</given-names></name></person-group>. <article-title>Evidence that SOX2 overexpression is oncogenic in the lung</article-title>. <source>PloS one</source>
<year>2010</year>; <volume>5</volume>:<fpage>e11022</fpage>; PMID:20548776; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0011022</pub-id><?supplied-pmid 20548776?><pub-id pub-id-type="pmid">20548776</pub-id></mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>K</given-names></name></person-group>. <article-title>Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma</article-title>. <source>PloS one</source>
<year>2013</year>; <volume>8</volume>:<fpage>e56324</fpage>; PMID:23424657; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0056324</pub-id><?supplied-pmid 23424657?><pub-id pub-id-type="pmid">23424657</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez-Pinilla</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Sarrio</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Moreno-Bueno</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rodriguez-Gil</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hardisson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Reis-Filho</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Palacios</surname><given-names>J</given-names></name></person-group>. <article-title>Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer</article-title>. <source>Modern Pathol</source>
<year>2007</year>; <volume>20</volume>:<fpage>474</fpage>-<lpage>81</lpage>; PMID:17334350; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/modpathol.3800760</pub-id><?supplied-pmid 17334350?><pub-id pub-id-type="pmid">17334350</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kopp</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Ormsbee</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Desler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rizzino</surname><given-names>A</given-names></name></person-group>. <article-title>Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells</article-title>. <source>Stem cells</source>
<year>2008</year>; <volume>26</volume>:<fpage>903</fpage>-<lpage>11</lpage>; PMID:18238855; http://dx.doi.org/<pub-id pub-id-type="doi">10.1634/stemcells.2007-0951</pub-id><?supplied-pmid 18238855?><pub-id pub-id-type="pmid">18238855</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Basu-Roy</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Zavadil</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Basilico</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mansukhani</surname><given-names>A</given-names></name></person-group>. <article-title>Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage</article-title>. <source>Mol Cell Biol</source>
<year>2011</year>; <volume>31</volume>:<fpage>4593</fpage>-<lpage>608</lpage>; PMID:21930787; http://dx.doi.org/<pub-id pub-id-type="doi">10.1128/MCB.05798-11</pub-id><?supplied-pmid 21930787?><pub-id pub-id-type="pmid">21930787</pub-id></mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>He</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>FF</given-names></name>, <name name-style="western"><surname>Zhau</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>LW</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>He</surname><given-names>D</given-names></name></person-group>. <article-title>Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2009</year>; <volume>389</volume>:<fpage>455</fpage>-<lpage>60</lpage>; PMID:19732746; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.bbrc.2009.08.165</pub-id><?supplied-pmid 19732746?><pub-id pub-id-type="pmid">19732746</pub-id></mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Akyuz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bernreuther</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Loers</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Laczynska</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jakovcevski</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Schachner</surname><given-names>M</given-names></name></person-group>. <article-title>Dermatan sulfotransferase Chst14/D4st1, but not chondroitin sulfotransferase Chst11/C4st1, regulates proliferation and neurogenesis of neural progenitor cells</article-title>. <source>J Cell Sci</source>
<year>2011</year>; <volume>124</volume>:<fpage>4051</fpage>-<lpage>63</lpage>; PMID:22159417; http://dx.doi.org/<pub-id pub-id-type="doi">10.1242/jcs.088120</pub-id><?supplied-pmid 22159417?><pub-id pub-id-type="pmid">22159417</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Payton</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Whitford</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Byrne</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bright</surname><given-names>RK</given-names></name></person-group>. <article-title>Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52</article-title>. <source>Mol Cancer Res</source>
<year>2007</year>; <volume>5</volume>:<fpage>133</fpage>-<lpage>44</lpage>; PMID:17314271; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-06-0245</pub-id><?supplied-pmid 17314271?><pub-id pub-id-type="pmid">17314271</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Saramaki</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Visakorpi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sutherland</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Mabjeesh</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Amin</surname><given-names>M</given-names></name>, et&#x000a0;al.</person-group>
<article-title>PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer</article-title>. <source>Cancer Res</source>
<year>2004</year>; <volume>64</volume>:<fpage>1589</fpage>-<lpage>94</lpage>; PMID:14996714; http://dx.doi.org/<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-3331</pub-id><?supplied-pmid 14996714?><pub-id pub-id-type="pmid">14996714</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Marchionni</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vuica-Ross</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cheadle</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Berman</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Schaeffer</surname><given-names>EM</given-names></name></person-group>. <article-title>Gene expression pathways of high grade localized prostate cancer</article-title>. <source>Prostate</source>
<year>2011</year>; <volume>71</volume>:<fpage>1568</fpage>-<lpage>77</lpage>; PMID:21360566; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/pros.21373</pub-id><?supplied-pmid 21360566?><pub-id pub-id-type="pmid">21360566</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bismar</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Demichelis</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Riva</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Varambally</surname><given-names>S</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kutok</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aster</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuefer</surname><given-names>R</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Defining aggressive prostate cancer using a 12-gene model</article-title>. <source>Neoplasia</source>
<year>2006</year>; <volume>8</volume>:<fpage>59</fpage>-<lpage>68</lpage>; PMID:16533427; http://dx.doi.org/<pub-id pub-id-type="doi">10.1593/neo.05664</pub-id><?supplied-pmid 16533427?><pub-id pub-id-type="pmid">16533427</pub-id></mixed-citation></ref><ref id="cit0096"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrne</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Balleine</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Schoenberg Fejzo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mercieca</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chiew</surname><given-names>YE</given-names></name>, <name name-style="western"><surname>Livnat</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>St Heaps</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Byth</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Karlan</surname><given-names>BY</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer</article-title>. <source>Int J Cancer</source>
<year>2005</year>; <volume>117</volume>:<fpage>1049</fpage>-<lpage>54</lpage>; PMID:15986428; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/ijc.21250</pub-id><?supplied-pmid 15986428?><pub-id pub-id-type="pmid">15986428</pub-id></mixed-citation></ref><ref id="cit0097"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alagaratnam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hardy</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Lothe</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Skotheim</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Byrne</surname><given-names>JA</given-names></name></person-group>. <article-title>TPD52, a candidate gene from genomic studies, is overexpressed in testicular germ cell tumours</article-title>. <source>Mol Cell Endocrinol</source>
<year>2009</year>; <volume>306</volume>:<fpage>75</fpage>-<lpage>80</lpage>; PMID:19041365; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.mce.2008.10.043</pub-id><?supplied-pmid 19041365?><pub-id pub-id-type="pmid">19041365</pub-id></mixed-citation></ref><ref id="cit0098"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tezuka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Horiuchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hosono</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Iida</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hatakeyama</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Miyaki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kunisada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tezuka</surname><given-names>K</given-names></name></person-group>. <article-title>Characterization of dental pulp stem cells of human tooth germs</article-title>. <source>J Dental Res</source>
<year>2008</year>; <volume>87</volume>:<fpage>676</fpage>-<lpage>81</lpage>; PMID:18573990; http://dx.doi.org/<pub-id pub-id-type="doi">10.1177/154405910808700716</pub-id><?supplied-pmid 18573990?><pub-id pub-id-type="pmid">18573990</pub-id></mixed-citation></ref><ref id="cit0099"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben Aicha</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lessard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pelletier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fournier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Calvo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Labrie</surname><given-names>C</given-names></name></person-group>. <article-title>Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells</article-title>. <source>Physiol Genomics</source>
<year>2007</year>; <volume>31</volume>:<fpage>295</fpage>-<lpage>305</lpage>; PMID:17712038; http://dx.doi.org/<pub-id pub-id-type="doi">10.1152/physiolgenomics.00097.2007</pub-id><?supplied-pmid 17712038?><pub-id pub-id-type="pmid">17712038</pub-id></mixed-citation></ref><ref id="cit0100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adham</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Eck</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Mierau</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sallam</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Paprotta</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Schubert</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hoyer-Fender</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Engel</surname><given-names>W</given-names></name></person-group>. <article-title>Reduction of spermatogenesis but not fertility in Creb3l4-deficient mice</article-title>. <source>Mol Cell Biol</source>
<year>2005</year>; <volume>25</volume>:<fpage>7657</fpage>-<lpage>64</lpage>; PMID:16107712; http://dx.doi.org/<pub-id pub-id-type="doi">10.1128/MCB.25.17.7657-7664.2005</pub-id><?supplied-pmid 16107712?><pub-id pub-id-type="pmid">16107712</pub-id></mixed-citation></ref></ref-list></back></article>